Podcasts about convatec

Play Episode Listen Later Feb 22, 2023 57:14

In this episode, we are feeling the love! Host and Counsellor Helen Farrell talks with Blogger & Stoma Advocate, Alannah Simpson, and Freelance Consultant and Stoma Advocate Patrick O'Dwyer, about their own perspectives on intimacy after stoma surgery. A quick warning... This episode contains frank discussions about adult intimacy and sex. Listener discretion is advised.

love sex intimacy bloggers stoma convatec

All things mental health and living with a stoma

mental health medical rachel green stoma convatec

Play Episode Listen Later Jan 24, 2023 51:09

In this episode, Host & Counsellor Helen Farrell chats with guests Rachel Green and Lynne Sinclair about the effects on mental health both pre and post stoma surgery, as well as living with a stoma and the importance of having somebody to talk to and not suffering in silence.

Building a Learning Culture

AXIOM Insights - Learning and Development Podcast

Play Episode Listen Later Dec 22, 2022 30:26

In this episode, we discuss building a learning culture. There’s been an ongoing conversation and focus on the ‘learning culture’ of an organization for at least the past decade, and there are many articles over that time which talk about the connection between a culture that supports individual learners’ interest in learning and connects it with the mission and goals of the organization. And over the past few years, we’re seen some statistics which suggest a learning culture is at least correlated with business performance. This episode looks at building a learning culture through the experience and guidance of Rachel Horwitz, the global director of learning and development at Convatec. Rachel describes how she and her team implemented a strategy to support a learning culture in the organization, structed around four pillars: Senior leadership partnership and sponsorship Curriculum Learning Operations Measurement

senior learning culture convatec

Holidays & Celebrations with a stoma

holiday holidays medical celebrations counsellor stoma convatec

Play Episode Listen Later Dec 20, 2022 34:12

In this week's episode, Host & Counsellor Helen Farrell chats with guests Jo Hunt, Anne Marks and Aisha Hussain about important holidays and celebrations throughout the year, and the impact this may have on a person's stoma routine. With festive celebrations upon us, Helen and our guests share ways that you can adapt and adjust your stoma routine during the holidays.

Support & advice before & after stoma surgery

advice surgery farrell stoma convatec

Play Episode Listen Later Nov 24, 2022 26:44

In this episode Host and Counsellor Helen Farrell chats with Anna Linnell, a Trained Stoma Nurse & Business Development Manager at Amcare Group and advocate Glen Neilson about support and advice that is available both before and after stoma surgery, and their own experiences with support. For free support sign up to our Me+ program, which is a service that offers tools and advice for every step of the stoma journey.

Implementation of an Evidence-based, Content Validated, Standardized Support Surface Algorithm Tool in Home Health Care: A Quality Improvement Project

Play Episode Listen Later Nov 22, 2022 42:54

On this episode of WOCTalk, we sit down with Jerri Drain, BSN, RN, CWON and Monica Timko-Progar, BSN, RN, ET, CWS®, FACCWS, two of the authors of the WOCNext® 2022 ePoster, “Implementation of an Evidence-based, Content Validated, Standardized Support Surface Algorithm Tool in Home Health Care: A Quality Improvement Project.” Jerri and Monica share with us the initiatives that caused them to develop the quality improvement project, the process of implementing and managing the use of the algorithm, and the overall success of the project. Episode Resources:Click here to view the abstract “Implementation of an Evidence-based, Content Validated, Standardized Support Surface Algorithm Tool in Home Health Care: A Quality Improvement Project”Click here to view the interactive ePoster from WOCNext 2022.Click here to view the WOCN Support Surface Algorithm Click here to view all WOCNext 2022 accepted abstracts and ePosters. About the Speakers:Jerri Drain, MBA, BSN, RN, has been a registered nurse for 25 years and a CWON for almost 20 years. She has 25 years of experience in home care. She has an MBA in Health Care Administration. She has worked in her role as Wound Care Director at Amedisys Home Health care for 17+ years, focusing on numerous Quality Improvement Initiations in the areas of wound and ostomy care. Monica Timko-Progar, BSN, RN, ET, CWS, FACCWS, has been in the Home Health Care industry since 1985. A graduate of the University of Pittsburgh, she has served in a variety of roles and positions in home health and hospice care starting as a field clinician. In 1993, she completed advanced training as a Wound, Ostomy, and Continence Nurse. Since that time, she has practiced in her area of expertise providing consultative services and education until functioning as the Corporate AVP of Wound Care Excellence at Amedisys Home Health and Hospice Care. She received her Certified Wound Specialist credentials in 2008 and is a Fellow of the American College of Certified Wound Specialists. She is a member of the Wound, Ostomy, and Continence Nurses Society™ (WOCN®), the American Board of Wound Management, and the Association for the Advancement of Wound Care. She has served as a board member for the American College of Clinical Wound Specialists serving in the role of treasurer and also Chairperson of the vendor committee. She has also participated as a Key Opinion Leader for ConvaTec ostomy division and is a charter member of the Coalition for at-risk skin (CARS) that recently constructed 21 consensus statements for at-risk skin with a subsequent article to be published. Monica is the author of several articles and has had poster presentations at both the WOCN Society and the Symposium for the Advancement of Wound Care (SAWC) conferences. She was a guest speaker at the WOCN annual conference in Nashville, TN in June 2014, and at the WOCNext® annual conference in Ft. Worth, TX in 2022. Monica and her Amedisys wound care colleagues were recently awarded the Clinical Practice Manuscript award by the Journal of Wound, Ostomy, and Continence Nursing (JWOCN®), recognizing their contribution to clinical care, for their quality improvement project entitled; “Implementation of an Evidenced Based Content Validation Standardized Ostomy Algorithm Tool in Home Health Care”.

Parenting & young people with a stoma

parenting medical young people counsellor stoma tom crawford convatec

Play Episode Listen Later Oct 31, 2022 36:07

In this episode, Host and Counsellor Helen Farrell speaks to advocates Tom Crawford and Tracey Rea, about being a young person with a stoma and a parent of a young person with a stoma. Helen, Tom and Tracey share their stories as well as practical advice and coping mechanisms for both young people and parents.

Wound Hygiene – What can it do for you

Leg Club Podcast

Play Episode Listen Later Sep 13, 2022 8:22

We welcome a new speaker, Bronwen Lafferty who is discussing “Wound Hygiene – What can it do for you” which defines chronic or hard to heal wounds with an early anti-biofilm intervention strategy. Bronwen was a District Nurse then qualified as a Tissue Viability Nurse and currently works for ConvaTec, one of our Leg Club Industry Partners.

hygiene wound bronwen convatec

Returning to work with a stoma

medical surgery returning to work stoma convatec

Play Episode Listen Later Aug 5, 2022 39:39

In this episode, Host and Counsellor Helen Farrell talks about returning to work with a stoma. Helen's guests in this episode are Pauline Fallows and Adrian Watters who both work for Convatec and Amcare Group and both have stomas and give their perspectives on returning to work as well as working life after surgery. Convatec and Amcare Group do not control what podcast speakers say in their testimonials/statements according to their own experiences.

How has the role of the CFO evolved over the years? | Bhavesh Shah, VP Finance and NBD Global Emerging Markets, ConvaTec Singapore

The Brand Called You

Play Episode Listen Later Jul 30, 2022 20:46

The people in an organization can only direct their efforts in the right direction when they have a leader to look forward to. Leaders can define workplace cultures that foster the accomplishment of common goals. What are the key attributes that an efficient leader ought to have? Is (s)he born with such qualities, or can be developed? We have your answers covered in today's episode of “The Brand Called You.” About Bhavesh Shah Global Finance executive with 25+ years of experience having worked in Asia and USA across industries (Consumer, Medical, and Pharmaceuticals). Have led major Transformation projects as Global CFO of large organizations. Worked on numerous acquisition and new business models and various transformation projects. --- Support this podcast: https://anchor.fm/tbcy/support

united states transformation leaders finance medical singapore consumer worked shah evolved pharmaceuticals global emerging markets convatec global cfo

Travelling with a stoma

uk travel travelling rachel green stoma patient advocates convatec

Play Episode Listen Later Jun 27, 2022 47:39

In this episode, Host and Counsellor Helen Farrell talks about travelling with a stoma with guests and Patient Advocates, Charlie Bremmell and Rachel Green, who have both travelled extensively across the UK and the world with Stoma bags.Convatec and Amcare Group do not control what podcast speakers say in their testimonials/statements according to their own experiences.

Adapting With Alex Garrett- Supply Chain Crisis Should Not Short Change Our Healthcare Needs

Alexander Garrett

Play Episode Listen Later Jun 15, 2022 17:56

I want to direct you to two reputable healthcare companies: LoCost Medical Supplies (https://www.locostmedicalsupply.com) and ConvaTec (https://www.convatec.com/ostomy/) are reliable in getting medical devices to you amidst the supply chain crisis . On Alex Garrett Podcasting, I advocate for the humbling of Big-Pharma as well during this period of inflation and moving forward out of this pandemic! People should not fearful they can't get their health needs met to the point of short-changing their health.

crisis healthcare adapting supply chains big pharma supply chain crisis convatec alex garrett

Adapting With Alex Garrett- Supply Chain Crisis Should Not Short Change Our Healthcare Needs

Alexander Garrett

Play Episode Listen Later Jun 15, 2022 17:56

crisis healthcare adapting supply chains big pharma supply chain crisis convatec alex garrett

Adapting With Alex Garrett- Supply Chain Crisis Should Not Short Change Our Healthcare Needs

Adapting With Alex Garrett

Play Episode Listen Later Jun 15, 2022 17:56

crisis healthcare adapting supply chains big pharma supply chain crisis convatec alex garrett

Raising Bowel Cancer Awareness

Diabetes Connections with Stacey Simms Type 1 Diabetes

Play Episode Listen Later May 11, 2022 39:31

In this episode, Host and Counsellor Helen Farrell, speaks with Clinical Exercise Specialist Sarah Russell and Bowel Cancer and Stoma Advocate Mark Gripton, about raising awareness during Bowel Cancer Awareness Month, and the effects of living with Bowel Cancer and a Stoma.Convatec and Amcare Group do not control what podcast speakers say in their testimonials/statements according to their own experiences.

medicine cancer raising bowel cancer awareness bowel cancer stoma bowel cancer awareness month convatec

Smaller, Smarter, & More Flexible: A look into Tandem's product pipeline

Play Episode Listen Later Jan 25, 2022 42:05

Take a deep dive into the future of Tandem Diabetes. In December, the company laid out an ambitious 5-year plan to update software, move to a smaller pump and ultimately a tubeless version. Company leaders say they want to think even bigger and we're talking to Chief Strategy Officer Elizabeth Gasser. We'll go through the short term changes Tandem has in the pipeline like the tiny Mobi pump and talk about philosophy and more. Tandem R&D Presentation (slides) Tandem R&D Presentation (replay) This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. Check out Stacey's book: The World's Worst Diabetes Mom! Join the Diabetes Connections Facebook Group! Sign up for our newsletter here ----- Use this link to get one free download and one free month of Audible, available to Diabetes Connections listeners! ----- Episode Transcription Below (or coming soon!) Please visit our Sponsors & Partners - they help make the show possible! *DEXCOM* Stacey Simms 0:00 Diabetes Connections is brought to you by Dexcom. Take control of your diabetes and live life to the fullest with Dexcom and by Club 1921 where Diabetes Connections are made. This is Diabetes Connections with Stacey Simms. This week, a deep dive into the future of Tandem diabetes. That company laid out an ambitious five-year plan to update software, move to a smaller pump and ultimately move to a tubeless version. company leaders say they want to think even bigger. Elizabeth Gasser 0:37 we have thermostats that manage our home temperature for us. We have self-driving cars we have on demand consumption services that you know, help us get our groceries and plan our meals. Come on. We should demand that level of ease of use in what we're doing here as well. Stacey Simms 0:54 That's Tandem Chief Strategy Officer Elizabeth Gasser. We'll go through the short term changes Tandem has in the pipeline like the tiny Mobi pump, she'll answer a bunch of your questions. We'll talk about the philosophy of the company moving forward, and more. This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. Welcome to another week of the show, I am only so glad to have you here. You know, we aim to educate and inspire about diabetes with a focus on people who use insulin. back in December Tandem made a big splash with their very first research and development presentation. If you haven't seen that, I highly recommend that it is rather long, but it's definitely worth checking out. I'll link that up in the show notes. And you can always find out more at diabetes connections.com. But in this R&D presentation, they laid out a very ambitious five-year plan for the company, which we're going to go through and talk about in detail today. Quick date check for you This interview was taped on January 10 2022. And we're releasing it on January 25 2022. So as of right now, the FDA has not approved anything new for Tandem no Mobile bolus that is in front of the FDA, and we'll talk about that and so much more. There were a few questions I didn't have time to get to or that you sent in after the interview. So I sent those to Tandem and I will come back after the interview. I'll update you and answer what I can also after the interview, if you are a health care provider, a diabetes educator and endocrinologist if you work in those offices. And a very specific question for you. Please come back. I'll make it quick. But I need some information. And I know you will can help me. Okay. My guest this week is Tandem Chief Strategy Officer Elizabeth Gasser she says Call me Liz. So I do. Her background isn't in diabetes, it is in strategy and corporate development, working at Qualcomm in their internet services division and at open wave systems, the world's leading Mobile browser provider at that time, and we talk about what it's like to come from that world to this one, I think it's really important to kind of get an idea for these individuals, you know who they are, who are making these decisions that affect so many of us. And of course, we go through that 10 to five year plan product by product. Liz, welcome to Diabetes Connections. Thank you so much for joining me, we have a lot to talk about today. Thanks for being here. Elizabeth Gasser 3:24 Oh, my pleasure. I'm excited to chat. Stacey Simms 3:27 There are a lot of items that Tandem announced in December, there's a lot to go through there. But I wonder if we could start kind of by backing up a little bit I've heard that you Tandem is kind of talking about being less of a hardware company, right, the pump, which will always be there in some way, shape, or form. But thinking more about the software, can we step back a little bit from the products here and talk a little bit more about kind of the philosophy or the vision? Oh, happy Elizabeth Gasser 3:53 to and if you've watched our R&D day, you'll you'll know that I do enjoy expanding on this particular topic. You know, as with any connected device, the minute you take a piece of hardware, and you give it a cellular connection or or a Wi Fi connection or a connection to the Internet, you've opened up the potential way to do an awful lot of creative things with both data but also with software, it really opens up the potential for continuous update functions and capability. And then also the ability to pull and push data back and forth from a device and and once you've done that, you you really crossed into that that world of the Internet of Things which requires you to be both an excellent hardware company, because you're managing the device, the functions of that device. It's touchpoints through connectivity, but it also requires you to be an excellent software company along the way. And if you look at the Tandem journey over the past five to seven years, you really do see the company's products moving down that pathway. Of course, the pump remains front and center for us it you know, the delivery of insulin is what we do. It's how we bring that therapy benefit to our users. But you also see a start to do things like the ability to update the pump software itself that unlocks new features and functionalities, including the algorithms which we can now continuously update, it allows us to update the different types of devices we integrate with, you'll see we've obviously moved from supporting Dexcom, G5, two, G6, and we're moving to G7. That's all done through software updates. And so it's really hard to be in this space and to be talking about connectivity and connected devices without also embracing the fact that you really are a software company and have to be incredibly good at it to deliver the value that you want to deliver to your customer base. Stacey Simms 5:59 I do remember years ago, our first pump and I say our work has been he was to when he got it. So it was definitely it was a group effort. But it was the Animas pump. And then a few years or months who remembers after he got that there was an update, where you could bolus from the remote meter. But we had to wait until our insurance would cover until we were up for a new pump. We had to wait I think three and a half years before we could get that. And so when we switched over to Tandem, I think we had the pump for a month when we there was a software update. So it really has changed. And to your point it is it is really remarkable to see that. Let's talk about, as you mentioned, the R&D presentation and some of what's in development. And of course, the usual disclaimer, I am sure that a lot of what we're going to talk about here is in development, it is not FDA approved. So there are limitations, I'm sure about what you can and cannot speak about. And if you can't answer something we totally understand. But let's just jump on in and kind of go through a list here. My listeners are extremely interested in getting some kind of update on the bolus by phone, which is in the FDA hands. But I have to ask you about Elizabeth Gasser 7:07 I figured you would like the the world is obviously a very unpredictable place these days, not least when it comes to projecting FDA timelines. That said, we still feel very confident and we're planning on an early 2022 approval. So I can't say much more than watch this space. But we're still leaning into the timelines. We talked about it R&D Day and looking at getting this much requested feature to our user base as soon as we can. Stacey Simms 7:39 Can you share with the rollout process may be? In other words, will it be a simple update to the T Connect app? Will there be some kind of required or prescription required online patient training? Elizabeth Gasser 7:49 Yeah, happy to and this this kind of ties to the conversation we were just having about, you know, being a software company, right? The introduction of this feature will be straightforward software updates. And so what does that mean? In practical terms, that means updating the iOS or Android Android application to the newest version, which will have the Mobile bolus capability. And at the same time, making sure you do a pump software update so that both sides of that dialogue can happen. And as part of the pumps software update, which happens through the Tandem device updater. There will be some online training, music click through to make sure that they understand the capabilities that we're introducing. And many of our users will be familiar with how you do that. Stacey Simms 8:33 Would there be a prescription needed for that kind of feature? A Elizabeth Gasser 8:36 Mobile bonus? Yeah, no, Stacey Simms 8:39 this may be a silly question. But can you share any details of what Mobile bolus actually means? In other words, I visioned this as Benny will take the his phone out and have full functionality controlling the pump from the phone. Is that accurate? Elizabeth Gasser 8:53 Yes or no, in that the primary goal of Mobile bolus is to allow for the delivery of a bolus from the phone. So in that sense, you're absolutely right, it will become for most of the day, the app will be the vehicle through which you can interact with the pump the piece, it won't do his full control of the pump. Meaning when you need to go in and look at changing settings, for example, that's not going to be in the Mobile bolus release. That's something that you don't have to do all the time, and can reasonably be done by taking the pump out and using the user interface on the device. As we get to the movie launch. Obviously, that will not have a screen. And so those control features, what we call full control will migrate into the app as well, for the movie pump. Stacey Simms 9:46 Of course, yes, that makes perfect sense. I'm not going to let myself get too far ahead because boy do I want to ask you about but to just stay on on Mobile bolus for one one or two more questions, but with Mobile bolus are there other There are features that will be on the phone, obviously, it Elizabeth Gasser 10:03 will marry with the app that currently exists today, right. And so that that is predominantly today, a secondary display tool allows you to see all of the things that are going on with the pump allows you to see blood glucose readings allows you to see insulin on board allows you to see the insulin delivery that you've conducted through the day. And so all of those features will remain. And the focus here really is on augmenting it with the ability to deliver a bolus from the phone. And so that sort of feels like it downplays. No. But it's incredibly, it's an incredibly exciting augmentation, and one that we think is an incredibly important first step towards that for control. Because it is the hardest use case, we have to get that absolutely right. Stacey Simms 10:49 Will that have share and follow? Is that something that you're working on for down the line? Or is that something that may come sooner? So really Elizabeth Gasser 10:56 good question. And we do recognize that share follow is incredibly important to our users and their families. Were continuing to look at where explicit share and follow capabilities for on our roadmap and what the best path to implementing that is, in large part because there's a diversity of CGM follow options out there, including our own Sugarmate application, which which can be used for blood glucose monitoring in a follow capacity. And so we don't have roadmap dates to share at this point in time, just know that we're sensitive to figuring out what the best possible implementation is for our customers here. And we want to make sure we're getting as much experience as we can, in the meantime, really understanding how to do good follow. And as I say, we're getting some of that through the Sugarmate app that we're operating, which actually just went live with the Dexcom real time API, right. And so there's a little complexity to thinking through what the best implementation model is. We're working on it and watch this space. Stacey Simms 12:00 Well, since you brought up Sugarmate, I have to ask with Sugarmate, which is if it's not clear, Tandem owns as you said, many people don't realize that is sugar beet, something that people could use, kind of as a bit of a workaround for a Tandem share and follow or Sugarmate only displays Dexcom data right now. Elizabeth Gasser 12:18 So today, sugar is explicitly a CGM companion application. It displays data from the Dexcom CGM. Over time we're looking at what features need to be added to that to ensure it delivers the best value proposition to our users. Really interesting Stacey Simms 12:33 stuff. All right, you segwayed beautifully into my question about Dexcom. How soon after Dexcom G7 is FDA approved, do anticipate it being available on the x two and again, is that a simple software update? Right back to our conversation, but first Diabetes Connections is brought to you by Dexcom. just about to talk about there. And one of the most common questions I get is about helping children become more independent. You know, those transitional times are very tricky elementary school to middle school middle to high school you get but I'm talking about using the Dexcom has made a big difference. For us. It is not all about sharing follow. I mean, that is very helpful. But think about how much easier it is for a middle schooler to just look at their Dexcom rather than do four to five finger sticks at school, or for a second grader to show their care team the number before Jim at one point, but he was up to 10 finger sticks a day and sometimes more and not having to do that makes his management a lot easier for him. It's also a lot easier to spot the trends and use the technology to give your kids more independence. Find out more at diabetes connections.com and click on the Dexcom logo. And now back to Liz I just asked about tandems planned integration of Dexcom G7 when it is approved and released. Elizabeth Gasser 13:53 We are intending to implement Dexcom G7 With both pump models so that means X2 and that means Mobi, down the road, our current goal, and this remains our goal is to deliver that within a quarter of FDA approval of the G7. And in terms of how they gets rolled out. I mean, it's very consistent with the software conversation we were just having right. The beauty of the software model is you know, as that gets approved, and as the implementation is ready, we'll be making it available to customers through a simple software update. Stacey Simms 14:26 Let's move on and talk about the December R&D presentation where this large plan, I think very ambitious and exciting was laid out for the next five years. And we've already mentioned a couple of the products. We're going to go through it in some more detail, but I am curious kind of, you know just what it was like that day and if you didn't see it or hear it, I can link up the video. I'm assuming that it's still up there. But I guess I'm asking this is what were you all talking about that day? There were so many people involved in the presentation, kind of doing handoffs and saying, here's the product, here's the software, here's the philosophy, it had to be a big deal. Tandem had to be a lot of relief when all the technology worked. And everybody got their presentations through with it. You were done. Elizabeth Gasser 15:07 Oh, absolutely. I couldn't agree more with that sense of it was momentous. And certainly at the end of it, we're all pretty tired. But no, it was, it was exhilarating, too. And I think, you know, we spend a lot of time because of because we're in a regulated space, we spend a lot of time talking day to day about the here and now the stuff that's approved, the stuff that's in market, and the reality is a lot of what we shared R&D day we've been working on for a while now. And you know, some of it's been skunkworks. Some of it's been more formal programs, you know, you just ticking along. And it was really exciting to have a vehicle to share a lot of that thinking and a lot of that innovation that we get to see day in day out. But we don't always get to tell the world about because of the rules and regulations in our space. Stacey Simms 15:59 Alright, let's talk about it as much as we can. You've mentioned Mobi several times, this had been referred to and I had been told this was not gonna be the name. So we didn't know that. But this had been formally referred to as T-Sport. Now, it is Tandem Mobi. Can you go through the features? Can you go through what this product is? Elizabeth Gasser 16:19 Absolutely. Where to start? First at it. It's the world's smallest durable pump. So if you're familiar with with the X2, it's half the size, that's really small, durable, four year lifespan hardware. So that in and of itself is exciting. In terms of where we go with the software on top of Mobi, it's going to support Control IQ. So same great algorithm that's in market today, it will be deployed on on both pumps in the same way. And so we get to bring that algorithm across the entire portfolio when Mobi launches, it will be controlled by phone as we were talking about earlier. And that means full control at this point in time, obviously, because there's no screen on the device itself. So what does that mean? Everything you need to do to interact with the pump settings, whether it's bolusing, whether it's looking at your statistics throughout the day, that will come from the phone, it will be charged inductively, which that you know, not something you don't really focus on. But that's that's pretty cool. With we're getting used to wireless charging for all of our consumer electronics devices not having to hunt around for a cord to plug it in. That's what we're doing with with Mobi as well. It'll sit on a little charging station, very easy, very straightforward, less pieces to worry about on pump bolus button. And this one we think is a little differentiated. Certainly in the on body arena, I think it will be the only one only pump out there of this size that has the option to fall back to a button push on the pump just to make sure because obviously, when you are interacting with your pump solely through a phone, we need to build in some measure of failsafe fallback, right if you find himself without the phone, and needs to bolus. And then lastly, waterproof. We're going to support waterproof capabilities through IPX8, which I think is pretty competitive. So lots of stuff packed into a really, really tiny device. Stacey Simms 18:25 I'm sorry, what is IPX? Eight mean? Elizabeth Gasser 18:28 The best way to articulate it, it's really just the standards we comply with and IPX eight means fully waterproof, you'll be able to swim and shower with it. Stacey Simms 18:36 One question about Mobi is I'm trying to visualize how it connects. My understanding is that it uses the standard pumping fusion set that like my son's Tslim currently uses, is that correct? It just sits closer to the body. Elizabeth Gasser 18:51 That is correct. The Mobi pump will work with the Tandem portfolio of infusion sets. And with the Mobi pump launch, we will also be introducing a shorter infusion set that four or five inches long, that allows for greater diversity of wear options. Stacey Simms 19:09 I'm so fascinated to see how this works because I'm a very visual person. So he could put it on like my son could put it on his arm and it kind of dangles off. Does it also stick to the body in a way? Or does it just kind of hang there on the tubing, the tiny tubing Elizabeth Gasser 19:24 work, we're working on the accessories to allow for a diversity of wear options, whether the belt clips or sleeves or a body worn adhesive patch through which you can that you can pop the pump into. So there's a variety of places you can push Stacey Simms 19:39 it interesting, alright. And like I said, I will link up so you can you can really dial down if you want to and see all of the features of everything we're going to talk about. But just for time limitations, we're not able to go through every single thing. Let's move on to the T slim x three that seemed to be next in the pipeline. What is that? Elizabeth Gasser 19:55 x three. That's the next iteration for the T slim X To pump. And really the focus there is to continue really honing the capabilities of the T slim form factor, right. And so we recognize that over time t slim continues to play a role in the portfolio, many of our users will continue to want a pump with a built in user interface. And so really the x three programs emphasis is on further developing the processor capabilities of that device, looking at battery life, looking at durability, reliability, looking at wireless software update capabilities, really to make sure that the T slim x two kind of line has continued vibrancy as part of the portfolio over time. And we're making the appropriate investments to support the diversity of software and user interfaces that we want to bring to the portfolio at large. So Stacey Simms 20:54 right now, it sounds like the changes you're talking about aren't something that, you know, I would look at the pump and say that is significantly different, right? Or that works completely did you've changed at all, it's making small improvements and things that the user, frankly, may not notice? Or will they're, you know, things will just run better, like you said battery life, that sort of thing. Are there significant changes that you could think of that would be coming to the pump itself? Elizabeth Gasser 21:16 Oh, no, that's absolutely right. I think this one's a little fun for me, because I come from the consumer electronics space, originally and spent 20 years you know, working on phones. And as you think about the types of releases, you do with consumer electronics, year to year, a lot of them are under the hood, that it's really focused on making it connect better, giving it more horsepower, making the battery last longer. And those things aren't always visible on the surface to a user, but may manifest through the quality of the user experience they get from interacting with that device. Stacey Simms 21:50 The next product is Mobi tubeless. We've talked about what Mobi is, I'm assuming this means know to tell me a little bit about Mobile tubeless. This is Elizabeth Gasser 22:01 a certain creativity and the naming convention there isn't so Stacey Simms 22:06 we shouldn't laugh. It's a very big deal. It's a very big deal. Elizabeth Gasser 22:09 No, I say that affectionately. And look, it's back to the conversation we were having on kind of the Mobi, shorter infusion set and different Bodywear options, more ways to air Mobi, right, we recognize that not everyone ultimately wants a pump with a tube. And so we've been pushing ourselves to say, okay, how can we improve the wearability and the wear option, so that we're reaching the broadest possible base of customers here. And, and this one's kind of an example of the things that we've had in the hopper for a while that not everyone gets to see, we took a little trip in the Wayback Machine and dusted off some of our earliest thinking on movie here. And maybe a tubeless infusion site option has been in our minds for a while. And so we felt it was the right time to bring that idea back to look at how to make it a reality as we get closer to the official launch of Mobi. And so this sits in the roadmap for Mobi as additional ways to utilize and engage with the product. And hopefully, it will give users choices, right? Some days, I don't want to wear my pump on my body, I might want to have it in my pocket and connect via a standard infusion site. Other days, I may be a little more active and find a really need to have a have a tubeless wear option, we get rid of the tube, the goal for us is to satisfy all of those use cases. Stacey Simms 23:34 And then the last one is the completely disposable patch pump that's in the pipeline. Is this a different form factor than Mobi? Is it a different design? Or is it similar? Elizabeth Gasser 23:44 So this is a different program? I can absolutely share that. I can't say a whole lot. This is one we want to keep fairly tight under wraps for competitive reasons. But the emphasis there is is very much on miniaturization. Got it. Can we really push the design envelope here on form factor for the device? Stacey Simms 24:06 You know, it's so interesting. We've been in this community as a family for 15 years. So now you're certainly not as long as many other people but in that time, we've seen and heard a lot of products, right? We've heard about new things coming. We've seen some really great advancements, we see things go away. This is a very ambitious portfolio that we're looking at and five years is it doesn't seem like a long time really certainly as I get older, it seems less than less. Seems everything's going more and more quickly. But a lot can happen in five years is the is the plan here that all of these products will exist together. As you said, you know, the movie tubeless you kind of made it sound like I might be able to take out my Tandem movie with the longer tube and then switch to the tubeless another day is the idea that all of these would exist side by side. Elizabeth Gasser 24:50 That's a great question, Stacey. I think the best way to answer that is to really reflect on the fact that we do fundamentally believe the day Diabetes space and particularly insulin dependent diabetes is a far more segmented market than every industry analysis would lead us to believe. You know, we often talk about type one and type two, as if those are the only segmentations that are relevant, we do actually think there's various needs, that we should appropriately be segmenting around, including, where preference form factor and user and interface size. And so as we look at the portfolio, we're really looking at how we can satisfy the broadest array of user needs. That may mean there is on occasion, some overlap in functionality between different products that sit in the mix. But the goal is really to provide the right device for the right group at the right time. And so as we think about where we go from here, the roadmap as we have sketched it out, for the 22 to 27 period really is very much about a tube pump offering with a screen, that's Tslim X2, a smaller form factor, more discreet phone operated screen, this option in the form of Mobi and there, the goal really is to create as diverse an array of wear options as we can to satisfy the needs of different user groups and their day to day activities, and then pass that as you think about the idea of a passionate disposable patch that exists as a third category that overtime will, we'll have to see how these different offerings play out with the segments that they're serving, and they are likely to coexist. Stacey Simms 26:39 So interesting. As we begin to kind of wrap this up, I did have a couple of questions from listeners I wanted to get to, and one of them was about control IQ, frankly, and any changes coming. In other words, we had heard a lot about changing the adjustable, changing the target rates lower than 160 and 180, that they are right now not the target rates. That's when the pump takes action, that kind of thing. And I remember hearing that there was something in front of the FDA, I don't know how much you can share. But can you talk to us about changes coming to control like you, yeah, happy to Elizabeth Gasser 27:09 talk about the design goals. In terms of control IQ today, it's delivering great outcomes. And in its current instantiation, I think one of the things that's helpful to understand about algorithms is that they're all going to work in different ways. It's like chocolate chip cookie recipes. If you think about it, lots of people have them, but it's how you put the pieces together and in what order and it's the secret sauce that affects how it tastes. Similarly, with algorithms, a lot of it comes down to how you put it together. And it's not always practical to compare from one to another. The real test is, you know, are you getting users to where they need to be in terms of, you know, being able to achieve their time and range goals, for example. So I think it's worth wrapping your head around that idea upfront. Now, having said that, for the control IQ roadmap, our next development frontier really is very much around personalization, and usability. While we're not going to get into very specific, you know, roadmap feature intersections at this time, we're exploring quite a bit here. And Jordan alluded to this a little bit in our R&D Day discussion, part of personalization for us does include exploring lower target ranges, and personalized target ranges, and looking at what it would take to deliver on those capabilities. Stacey Simms 28:32 Here's a real speculative question that I don't expect you to answer. I'm hearing in the DIY space, that more and more people are coming up with algorithms that don't need meal announcements, or don't even need meal boluses. Is that something that Tandem is working on for an algorithm? Or I guess the real personal question is, could you please Liz, help me because my son forgets to bolus for many meals. He's 17. He's very independent. But oh my gosh, when I see people working on things like that, I just feel like that would be life changing. Elizabeth Gasser 29:05 Yeah, mail handling unannounced meals on lounge consumption. Yeah, it's the hardest thing to confirm it with the algorithm here. It is fair to say that as part of our ongoing roadmap explorations, we are looking at what it means to improve unannounced meal handling. Stacey Simms 29:24 I'll take it. I'll take it. Thank you. Another question came up about new infusion sets. And you had mentioned this, you touched on this briefly, but we talked to folks at ConvaTec who make many of the infusion sets and they were talking about longer life improvements to the cannulas or those sorts of things coming to Tandem. Yeah, so we Elizabeth Gasser 29:46 did talk a little bit about our goals here. During R&D day. You know, it is only one piece of the system but we do recognize infusion set issues can be a real pain point for customers and so we have programs IPs that are ongoing. Some of them are internal driven by us. Some of them are in conjunction with our partners working on a diversity of things. Some of it is extended wear time, which we know is important. But we're also looking at insertion, ease and usability there, we're looking at how to reduce infusion site failures, specifically around occlusions, obviously continuing to look at things like adhesives, reduction of material waste. And so this one, it's a pretty diverse view that we're taking. It's not all necessarily anchored solely in the idea of extended wear, I can't give you any specific breaking news in terms of you know, what we're coming up with and the products we'd like to bring to market. But this one we're paying serious attention to, we recognize that our customers want to see progression here. Stacey Simms 30:57 Yeah, I have been amazed since day one of pumping, I feel like the infusion sets have, at least for us, and everybody is different. And everybody's skin is different. Everybody's insertion technique is different, which is part of the problem. But you know, I've just been amazed to me, that has always been the weakest link of pumping. And the idea that I'm using pretty much the exact same infusion set that I put on my son's body 15 years ago, just with all the advances that we've had to me, that's the one that needs much more attention. So I'm really, really glad to hear you're working on that. Alright, so this is not a question. But this was a thought that ran through many of the comments. Many people wanted to say, thank you for getting this is terrible. Thank you for getting control IQ through the FDA before COVID. Because oh my gosh, nothing has happened since like, this was approved, what December of 2019. And many people started getting it I think the earliest was January of 2020. And the diabetes community it feels like very little, although there have been there have been approvals. But it feels like everything is moving so slowly now. So I'm sure Tandem is happy about that. But I know the community as well. So I'm not sure if I can even ask you to answer. There's no question there. But thank you. Elizabeth Gasser 32:05 Oh, I'm not sure there's any good answers there either. Stacey, I certainly applaud the the yeoman's work going on at the FDA to manage through this crisis. And certainly while it's frustrating to have extended approval cycles, and yes, in retrospect, a blessing that we secured approval prior to COVID. I can't do anything but feel respect, admiration and a little bit of sympathy for our friends at the FDA. Yeah. And Stacey Simms 32:35 again, I don't know if you can answer something like this. Have you heard that they are they're kind of making their way through it just seems like there was such a log jam, I understandably so any feeling any word that they are kind of clearing the deck, so Elizabeth Gasser 32:47 to speak? I don't think it's my place to comment on my workflow there. I Unknown Speaker 32:50 tried. You can we do have good Elizabeth Gasser 32:52 back and forth with the FDA, you communicate with them regularly. And so they continue to engage with the industry constructively, productively. Stacey Simms 33:02 Alright, before I let you go, you don't live with diabetes, as you said at the very beginning, you know, you come from a software background and that sort of thing. But what is it like to come from that and work in in diabetes, where the work that you do I mean, here I am complaining about infusion sets, and, you know, change the bolus, from what you know, before it reaches 180? You know, we're talking about all of these little things add up to such quality of life issues for people, you know, what does it been like for you to work in this space? Elizabeth Gasser 33:28 That's a great question. It's one that I think you're the first person to ask me to reflect on. You know, I think it is both sobering and invigorating, sobering because, you know, when you come from a world that's, you know, focusing on clicks and engagement and eyeballs, and consumption of media, you can get lost in the little things, and really stepping back and recognizing just the enormity of what type 1 diabetes is, and the burden it places on people's lives, day to day, and feeling like I can show up to work and even in a little way, help with that. That's sobering and profoundly rewarding. It's also invigorating, because, you know, coming from a consumer electronics environment, you see what's possible with the technology as it exists today, and many of those technologies have not yet come to medical devices in a very fulsome way. And so I certainly get out of bed day in day out wondering how we can help therapy benefit from all of the innovation that is going on, in the consumer electronics world, right. You know, we have thermostats that manage our home temperature for us. We have self driving cars we have on demand consumption services that you know, help us get our groceries and plan our meals. I don't mean to trivialize the differences that are involved in translate I think that to medical devices, but I also think as you look at that and say, Come on, we should demand that level of ease of use in what we're doing here as well. And so that that's profoundly motivating. Stacey Simms 35:13 That's great. Well, thank you so much for sharing so much information for answering what you could answer. And I hope we talk again soon. My pleasure. Elizabeth Gasser 35:21 Thank you, Stacey. Stacey Simms 35:27 You're listening to Diabetes Connections with Stacey Simms more information at diabetes connections.com, including the link to the research and development presentation. If you'd like to watch that or just listen to it, I will link that up over on the website along with the transcription. I really appreciate your patience with the transcriptions. I think we do a great job. But my transcription software doesn't speak diabetes, I try to teach it but it is a little unreliable. That way we go through and try to catch the big stuff. But if you do see anything egregious, or very confusing, please let me know. And I can pretty easily fix that. I want to take a moment and address a couple of the questions that we ran out of time with Tandem or your questions came in late. I'm going to do that in just a moment. But first, I mentioned at the beginning of the show that I had a question for healthcare providers, I have a question for you, I have a favor to ask of you. You may have heard me talk about Club 1921. I mentioned it right at the beginning of the show, I'm only talking about if you're at the end of some of the podcast episodes, and in the Facebook group, we are in beta. It is my new project. It's all about events in the diabetes community nationwide, any type of diabetes anywhere in the United States. I need your help, because it's very easy for me to find the big events, right friends for life, JDRF, even ADA stuff online. What I would like to add to the website, and what I think will be vital to its success are all of the events going on in your hospitals. Almost every hospital has a nutrition program for people with type two, an education program for gestational diabetes, things like that. They can be virtual, they can be in person, but I need to find those programs, I need to get into those hospitals, I need to reach the people who want to add those events. This is not a community calendar, where I hope a couple of groups post their events. And we all go from there. I want this to grow into a site where 1000s of people with diabetes, any type of diabetes, find their community find help find what's being offered. And I know that these hospitals want to connect with these folks. So if you could help me do that point me in the right directions to meet with the association's it doesn't have to be one on one with hospital systems, although that would be great, too. But whatever you think might be a help, I would really appreciate it, you can email me Stacey at diabetes connections.com, you can message me on social media, thank you so much, because this will only succeed if we reach out beyond the community that we are already talking to. So thanks. Okay, let's get to the kind of leftover questions from Tandem, the most common one had to do with international rollout. And I unfortunately, I don't really have any good answers for you. I'll tell you what Tandem said I asked specifically about Australia, I had two people who emailed me asking about what is going on in Australia with the rollout of Control, IQ, nevermind all these other features. And they just said we do not have an update at this time. And then asking about other international markets. So let me read that response in full Tandem says we have launched in a large majority of the international markets, and we're near to medium term focuses on ensuring we work to make our technology broadly available to these customers. We don't have anything to disclose with regard to additional markets at this time. So I know not the answer you were hoping for. I will keep asking on this one. And I do apologize, we are a very US centric podcast because I am US centric. But I appreciate the reminder. And I will try to keep that focused and you know on my list of questions as we move forward with lots of different technology this year. And then I had also asked them about changes to the current controller queue algorithm. I had asked during the interview if it could take action at a lower number than 160, which is where it jumps up to basil and 180 where it gives an auto bolus at 60% of the bolus rate that the person programs in and Liz did answer that question in the abstract, but I wish I had pushed on it. So I followed up because I thought I had heard that Tandem had already submitted a change on that to the FDA. They responded quote, as Liz mentioned in the interview, we are working on personalization features which include lower targets and thresholds. We've begun to engage the FDA and started our design work, but we're not currently providing any of the feature details and quote, I will add this editorial comment. Every pump company I talked to has started out saying we're going to have lower ranges, we're going to have tighter ranges, we're going to have customizable ranges and every time it hits the FDA that kind of starts to change set You know, Omnipod, if you'll go back and listen to the interviews from two or three years ago, they were going to submit with I think it was 80 to 100 as one of their ranges. And that didn't happen they've submitted with higher ranges, just like Tandem did. I think, again, this is my speculation, I think these will all gradually come down. But if you are looking now for tighter control with these hybrid closed loops, you might want to go the DIY route. Although if you keep your pump in sleep mode, you know you're sleeping beauties with Tandem it's trying to keep you at like one 12.5 The whole time you just have to remember to bolus which works beautifully for some people, and not at all for the person in my house. Okay, before I let you go quick look ahead. Of course in the news is every Wednesday we do that live on Facebook, and YouTube and I added LinkedIn this week. My goodness, we're also live on Instagram a little bit later, still can't do all of that at once we're working on it. And then I turned that into an audio podcast episode that is released on Fridays, upcoming longer format shows we'll cover more technology including a new pump called Sigi. We've also got some really interesting community interviews. What is it like right now when you live with type one, but you also live with another autoimmune condition that makes it very difficult to get a COVID vaccine. And I'm going to be talking to some of the Joslin medalists who are this is a theme right living longer with type one and the issues that have cropped up for them that nobody really far, we would have to think about so I'm excited about that and so much more. Thank you as always to my editor John Bukenas from audio editing solutions. Thank you so much for listening. I'm Stacey Simms. I'll see you back here soon until then, be kind to yourself. Benny 41:48 Diabetes Connections is a production of Stacey Simms media. All rights reserved. All wrongs avenged

covid-19 united states world australia internet club meaning product diy mobile ios fda diabetes wifi audible iq smarter pipeline api flexible internet of things smaller g7 r d ips qualcomm tandem wayback machine cgm g5 x2 jdrf mobi g6 joslin sigi dexcom animas unknown speaker ipx stacey simms omnipod diabetes connections convatec android android john bukenas dexcom g7 tandem diabetes dexcom cgm t sport

Bonus 19: Covid-19 Impact on the WOC Nursing Practice

Diabetes Connections with Stacey Simms Type 1 Diabetes

Play Episode Listen Later Jan 7, 2022 31:05

On this special bonus episode of WOCTalk, we sit down with Janice Beitz, PhD, RN, CS, CNOR, CWOCN-AP, CRNP, ANEF, FNAP, FAAN, to discuss the impact of COVID-19 on the wound, ostomy, and continence (WOC) nursing practice in conjunction with the recent webinar titled “My Favorite Perfume Scent is Hand Sanitizer: Covid-19 - Impact on Contemporary Ostomy Practice”. This webinar is available to view on-demand through the WOCN Continuing Education Center (CEC) and awards 1.0 Contact Hours. This webinar discussed the impact of Covid-19 on the American population, innovations growing out of the pandemic, and clinical implications for future ostomy care delivery and clinician self-care needs.This podcast and the webinar are supported by an educational grant from ConvaTec. The WOCN® Society does not endorse specific products and services.Episode ResourcesTo view the on-demand webinar “My Favorite Perfume Scent is Hand Sanitizer: Covid-19 - Impact on Contemporary Ostomy Practice”, click here.To learn more about WOCNext® 2022: A Global Education Event from WOCN® and WCET®, click here.To view the online Journal of Wound, Ostomy, and Continence Nursing (JWOCN), click here.

covid-19 american phd impact journal rn cs wound woc faan nursing practice ostomy fnap convatec wcet woctalk

In the News... Tandem's tiny pump, more stem cell progress, a new Rufus the Bear & more!

Play Episode Listen Later Dec 10, 2021 8:03

Our top stories In the News this week... Tandem Diabetes shares a big R&D update, laying out their product pipeline for the next 5 years. More stem cell progress, this time from Viactye, a look at another non-invasive CGM claim, big news for Rufus the Bear from JDRF and Stacey spends some time remembering Beyond Type 1 CEO Thom Scher. -- Join us LIVE every Wednesday at 4:30pm EST Check out Stacey's book: The World's Worst Diabetes Mom! Join the Diabetes Connections Facebook Group! Sign up for our newsletter here ----- Use this link to get one free download and one free month of Audible, available to Diabetes Connections listeners! ----- Get the App and listen to Diabetes Connections wherever you go! Click here for iPhone Click here for Android Episode transcription below: Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and these are the top diabetes stories and headlines of the past seven days. As always, I'm going to link up my sources in the Facebook comments – where we are live – we are also Live on YouTube and in the show notes at d-c dot com when this airs as a podcast.. XX In the News is brought to you by The World's Worst Diabetes Mom, Real life stories of raising a child with diabetes. Winner of the American Book Fest Prize for best new non-fiction. Available in paperback, on Kindle or as an audio book – all at Amazon.com. You can also get a big discount right now at diabetes-connections.com – use promo code celebrate to save $4 XX Our top story, big news from Tandem as they lay out their product line for the next 5 years. Still waiting for FDA approval for bolus by phone.. once that comes through next up is Mobi, that's brand name for what we've all been calling T-Sport until now. Then there will be an X3 pump, then Mobi goes tubeless, then a true disposable patch pump. They also mentioned some software upgrades. A lot can happen in 5 years but exciting to see it laid out. A lot more to come here, we're working on having Tandem on the show soon. https://investor.tandemdiabetes.com/events-and-presentations XX Over at Insulet, CEO Shacey Petrovic says they no longer expect FDA approval for Omnipod 5 in 2021. After all, that's in just a couple of weeks. She spoke at a NASDAQ investor conference and said it's not any kind of problem, just the COVID backlog at the FDA. Petrovic says she is – quote – “eminently confident in our submission.” https://www.medtechdive.com/news/insulet-omnipod-5-delay-fda/610981/ XX More stem cell research news, this time from Viactye. University of British Columbia and Vancouver Coastal Health. showing that a tiny implant infused with stem cells can help the body produce insulin on its own. Fifteen patients living with Type 1 diabetes participated in the study, which included the insertion of a device the size of a quarter in their abdomen. Each device contained millions of lab-grown cells that were “coached” into becoming insulin producing beta cells. Six months later, the cells had started producing tiny bits of insulin. Next year the team plans to do the procedure without immunosuppression drugs. The ultimate goal to have somebody who stops taking insulin and not have to take any anti-rejection drugs. We first talked to Viactye about this in 2016 – I'll link up that episode. https://www.ctvnews.ca/health/stem-cell-based-treatment-may-help-type-1-diabetes-patients-produce-insulin-canadian-study-1.5694725 XX The White House continues it's push to pass Build Back Better.. focusing a lot this week on the insulin co-pay cap. It's passed the House and if the Senate approves.. government and private insurers have to cap the cost to the patient at $35 for a 30-day supply of insulin. Nothing in the bill for those without insurance. Btw 20 states and DC have passed similar copay limits. I did see late this afternoon on Twitter a few reps who want to change the language to include the uninsured. We shall see.. XX The Free Style Libre 2 App is now available for Android. Approved earlier this year, it's now actually available for download. The Libre 2 version features optional real-time alerts for both low and high glucose levels, without the need to manually scan the sensor to trigger those alarms. You do still need to scan to see the actual number. https://www.abbott.com/corpnewsroom/diabetes-care/freestyle-libre-2-now-connected-to-your-iphone.html XX Dueling lawsuits from Abbot and Dexcom. Abbot filed suit last week – it's sealed but has to do with a 2014 settlement agreement. That agreement gave the companies cross-licenses to patents related to glucose monitoring. It also included agreements lasting through March 2021 not to sue each other for patent infringement or challenge the patents' validity. We told you back in June of this year that Dexcom filed the first suit, Abbott countered the next day. This seems like an additional legal maneuver in the same case. https://www.reuters.com/legal/transactional/abbott-sues-dexcom-over-glucose-monitoring-patent-settlement-license-2021-12-02/ XX Another entry for the non-invasive blood sugar monitor rumor mill.. K-Watch Glucose smartwatch has a disposable part underneath that features something called “micro-points” that will measure blood glucose. The company says, “Although the wearer might feel some slight pressure, there is no breaking of the skin and therefore no pain.” Not sure those two thoughts really go together – enough pressure can be uncomfortable enough.. but we shall see. The coverage here talks about clinical trials and getting this on the market late next year. I went to the actual clinical trial recruitment site – and I'll link that – it says the trial started in November but it also says it hasn't started recruiting. I know I'm the dream killer with the non invasive monitoring stuff. I do believe it'll get here I promise! But I think the coverage of most of these items Is irresponsibly based on rumors. https://clinicaltrials.gov/ct2/show/NCT05093569 https://www.notebookcheck.net/Painless-continuous-blood-sugar-monitoring-on-the-horizon-for-US-199-thanks-to-the-K-Watch-Glucose-from-PKVitality.582622.0.html XX there's a follow up to a fun story I broke back in 2019 – the merger of Jerry the Bear and Rufus the Bear with Diabetes. Rufus is getting a big it looks like the Rufus outside with the Jerry the Bear educational interactive stuff and the app. The price is 22-dollars! A far cry from the first version of Jerry which we gave away a few years ago and cost hundreds of dollars. This is really great and I would have absolutely bought it for Benny if it was out when he was little. How'd I break the story? I interviewed the heads of JDRF and Beyond Type 1 when they announced their alliance– and I asked what was going to happen to the bears almost as a joke. They said, nope – they told me then.. only one bear would make it. https://www.prnewswire.com/news-releases/jdrf-announces-the-relaunch-of-rufus-the-bear-with-diabetes-301437309.html XX I want to take a moment and remember Thom Scher – the CEO of Beyond Type 1 who died earlier this week. I went back and listened to that interview we did back in 2019 – the one where he and JDRF told us about Jerry and Rufus… and a lot more. It was one of many times we talked on and off the podcast. I didn't know Thom as well as many others in the diabetes community. We only met in person a few times – first in 2018 at the Diabetes Mine conference and again in 2019 at FFL – where we talked about working together more.. sort of noodling out the possibility of bringing the podcast into the Beyond Type 1 content. Thom was a terrific interview – not afraid to go on the record and very accessible. I remember once I warned him that I had some tough questions from the community about get-insulin dot org because beyond type 1 takes money from the insulin makers. He welcomed it and answered the questions other people would have avoided. I just read that Thom was 33 when he died. So incredibly young. He believed in what he did.. he wanted to make life better for people with diabetes. And the world is little emptier without him today. XX Before I let you go, a reminder that the podcast this week is with the executive team at ConvaTec – the people who make infusion sets for tubed pumps, including the new 7-day set for Medtronic. you can listen to wherever you get your podcasts or if you're listening to this as on a podcast app, just go back an episode. Next week it's a first for me, I'm going to do a “favorite things” episode. That's In the News for this week.. if you like it, please share it! Thanks for joining me! See you back here soon.

The seven-day infusion set is here. What's next from ConvaTec Infusion Care?

Diabetes Connections with Stacey Simms Type 1 Diabetes

Play Episode Listen Later Dec 7, 2021 43:38

When we heard about a new seven day infusion set approved this past summer, we had a lot of questions! We've been told since the very first day of pumping to only use the inset for 3 days tops and to always rotate the site. How did they get seven days out of one of these without skin irritation and with good absorption? We asked the folks who make the inset to come on the show and explain. Turns out, ConvaTec Infusion Care makes the insets for Medtronic, Tandem, Ypsomed, Dana RS and Roche pumps. So while I started off talking about the longer-wear version, the conversation you'll hear includes everything from proper insertion technique, their challenges teaching users best practices, improvements they're making to the cannula and more. In this interview you will hear: John M Lindskog, President & COO, Matthias Heschel, Vice President, Research & Development and Intellectual Property Rights and Dr. Kerem Ozer, Director Infusion Care Clinical Development Good article about using insets correctly and understanding the different types. Check out Stacey's book: The World's Worst Diabetes Mom! Join the Diabetes Connections Facebook Group! Sign up for our newsletter here ----- Use this link to get one free download and one free month of Audible, available to Diabetes Connections listeners! ----- Get the App and listen to Diabetes Connections wherever you go! Click here for iPhone Click here for Android Episode Transcription Below: Stacey Simms 0:00 Diabetes Connections is brought to you by Dario Health manage your blood glucose levels, increase your possibilities by Gvoke Hypopen, the first premixed auto injector for very low blood sugar, and by Dexcom take control of your diabetes and live life to the fullest with Dexcom. This is Diabetes Connections with Stacey Simms. This week, how much have you thought about the way your insulin pump connects to your body? Honestly, it's where a lot can go wrong. The people who make the insets know that they have come a long way. And they're trying to make it better. Matthias Heschel 0:40 It's what some people call their Achilles heel in the arm therapy were very much aware of it. And our approach simply is instead of doing product design at the drawing board, to the product design in the field, really taking the patient at the core of our design process, really understanding behaviors, understanding what could go wrong, and then design the product accordingly. Stacey Simms 1:05 That's Dr. Matthias Heschel, head of R&D for ConvaTec infusion care. He, the CEO and the Medical Director sat down with me to talk about longer were tips for users and what's next for this really important part of pumping. This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider. Welcome to another week of the show, you're always so glad to have you here. We aim to educate and inspire about diabetes with a focus on those who use insulin. I am really excited and happy to talk to the guys from ConvaTec. This week, you know, they were frank, they were really up for anything. And I have said for years that insets are the weak link in pumping. And they really opened my eyes to some of the issues and what we can do as users or you know, as parents of users to make things a little bit better. And of course, they're working on improvements as well. But before we jump in a little bit of housekeeping, I want to talk about the rest of the year schedule for the podcast, I can't believe we're in well into December at this point. Right now the plan is to keep going with these longer format. The interview shows that air on Tuesdays, and we'll have that there shouldn't really be any interruption or any week skipped through the rest of the year and into January. I'll let you know if that changes. But that is the plan right now. As for the newscast, I will probably not have a newscast on the 22nd of December. Again, I reserve the right to jump in and make a liar out of myself. There is breaking news sometimes late December is when the FDA makes a lot of decisions. So we could have some breaking news. But I would say right now, it looks like at least that one date will not have the live newscast on Wednesday on Facebook, Instagram and YouTube. And so then I will not be turning it into one because that would be a podcast on Christmas Eve and I don't think there's a lot of demand for you to listen on Christmas Eve but you tell me if there is I'm happy to serve and try to put all that together. Another quick announcement and I'm actually going to talk more about this after the interview is that book number two is in the works. The second World's Worst diabetes mom, I signed on the dotted line to deliver that next year. So we have a timetable. We have a theme. I have lots of stuff. I'll tell you about that again after the interview, but man, I'm really excited about it. Alright, a little bit more about our guests. ConvaTec infusion care makes insets for both of the tubed pumps available in the US they make for Tandem they make for Medtronic, they don't make Omni pods. They also make insets for Ypsomed and other tubed pumps abroad. But if you use a tubed pump in the US you use their products. In this interview you will hear John Lindskog The President and CEO, Dr. Matthias Heschel, the head of R&D, research and development and Dr. Kerem Ozer, the Medical Director, I worry a bit about three voices. I mean, really, it's for with mine, but we do I think we do make it clear. And there is always a transcript over at diabetes connections.com at the episode homepage, if you find it easier to you know some people follow along, reading as they listen. Some people prefer to read my transcription software. Let me tell you got a workout on this one. It doesn't speak diabetes very well to begin with. And as you can imagine, there was a lot of technical stuff but we did it we got it and it's there for you. But I think that these three were very frank and gave us a lot of information a national here. They have a question for us. That's coming right up but first Diabetes Connections is brought to you by Dario health. Bottom line you need a plan of action with diabetes. And we've been lucky that Benny's endo has helped us with that and that he understands the plan has to change. As Benny gets older you want that kind of support. So take your diabetes management to the next level with Dario health. Their published studies demonstrate high impact results for active users like improved in range percentage within three months reduction of a one C within three months and a 58% decrease in occurrences of severe hypoglycemic events. Try Dario's diabetes success plan and make a difference in your Diabetes management, go to my dario.com forward slash diabetes dash connections for more proven results and for information about the plan. John, Matthias and Kerem, thank you so much for joining me. We have a lot to talk about. And I feel like I've ever been to the company at my disposal. Thank you so much for taking the time to do this. John Lindskog 5:20 Thank you, Stacey. This is John and thanks for having this opportunity to talk with you. Maybe just a couple of words of ConvaTec infusion care. I'm the president and CEO of that part of ConvaTec. We are based out of Denmark and out of Mexico, we have one plant making a few sets in Denmark, and we have two plants almost side to side in Mexico, and also is fully dedicated to making few sets for subcutaneous infusion. Today with me, I have the Matthias and I Kerem and if you could just kind of introduce yourself briefly. Matthias Heschel 5:58 Yeah, this is Matthias. I'm heading research and development at ConvaTec Infusion Care. I've been with the company for 10 years. Just happy to be here. Dr. Kerem Ozer 6:07 Hi, everyone. I'm Kerem Moser and I'm the medical director for ConvaTec infusion care. I'm an endocrinologist by background. I've been with ConvaTec for about four months now. And prior to that I was in practice seeing endocrinology and diabetes patients for about 15 years, and very excited to be here. Stacey Simms 6:28 Wonderful. Well, thank you all so much for joining me. We have a lot of questions, questions for my listeners questions that I have as a mom of a kid who has used insets since he was two years old. So let me jump in and ask about the newest infusion set as I see it, which is with Medtronic and Matthias. Let me ask you about this if I could. we're hearing really interesting things seven day up to seven day wear, which I believe rolled out in Europe first is now approved in the United States. How I don't want to ask you to give any trade secrets away. But how do you get it to last so long when we've been told for years that two to three days is the maximum for an infusion set? Matthias Heschel 7:03 Yeah, actually, the answer is very simple. Stacey. Medtronic, they provided quite some details about the year back at the virtual conference. So Medtronic, they added a proprietary connector, which connects the tubing to the pump reservoir. And this connector stabilizes the instrument. On top of the canula, a new tubing, which contains the preservatives, contains the antimicrobial effect of the preservatives. And the last thing is that we added a new adhesive to keep the infusion set on the body for up to seven days. So basically three things. New connector, new tubing, containing preservatives and a new adhesive. Stacey Simms 7:48 So it was kind of a partnership with Medtronic. It's not all on the inset itself. Matthias Heschel 7:52 It's a partnership with Medtronic, and they in general, talking about new product development, future products. It's all at system level. So we cannot just develop a new infusion set. We need to take the reservoir into account we need to take algorithms into account so it's it's always a close partnership with pump manufacturers. Stacey Simms 8:15 how have people received it? Or is it working well, is the adhesive doing okay, on people's skin? Matthias Heschel 8:20 It seems so we have received some first indication Medtronic percent that results at the diabetes technology meeting here this week, actually. And that has shown that there are lower occurrence of hyperglycemic events. There are fewer occlusions. And I think the average wear time was seven days. So it seems that the patients that have come on to an extended wear infusion set are really happy and the infusion sets perform as designed. Stacey Simms 8:57 Before I move on from this one more question for you Mateus if I could. I'm curious, are you working with other pump companies on longer where infusion sets? Or is this going to be a Medtronic exclusive for the foreseeable future? Matthias Heschel 9:10 Well, extending the wear time of infusion sets, that's the unmet need, number one among all patients, so and that's in general interest from all pump manufacturers to have extended wear products in the portfolio. So yes, we're working on the portfolio of infusion sets. Stacey Simms 9:30 Kerem, let me move over to you if I could for this question. As a parent of a child with type one. We were schooled early on the importance of rotating sites, right? You can't let an infusion set go in the same part of the body over and over again. But most kids and frankly most adults I've talked to who use these products do kind of have a favorite spot. The body. Can you talk a little bit about Yes, I guess there the importance of rotating, but something like a seven day wear or what's coming in the future. Is there a possibility that it could be a little less important? to move that around, or am I dreaming? Dr. Kerem Ozer 10:02 That's a really good question, Stacey sort of looking forward, just taking a quick step back, just like you said, the importance of sort of proper rotation is something we always talk about in clinic yet in real life, we know that people have their favorite sites. And part of the idea of the rotation, of course, is to reduce scarring and is to reduce lipohypertrophy. I know your listeners will be very familiar with this. But of course, when we say lipohypertrophy, we're talking about sort of the hardening that bumpiness of the layer right under the skin, that subcutaneous area. And when I think about lipohypertrophy, there are several factors that increase that risk, you know, multiple daily injections, pumps, continuous glucose monitors, sometimes the type of insulin being used, and that really changes from person to person reusing pen, needles, all those factors, even higher insulin doses tend to cause more of a higher risk, higher diabetes, duration is a higher risk. Now, when I think about those factors, some of them are you can't change those like diabetes, duration. Some of those factors, you can change by rotating things, when you look at something like extended wear, I think one advantage is you are going to need to change it out less often. So you're technically changing it, you know, less often, it's probably best practice to still change the site and rotate the site. But one thing I think that's going to be even clearer, and I see this all the time, you know, when I talk with my patients, is, I think it's going to be important to realize subtle changes in the characteristics of that site, even before you start feeling hardening of the skin, even before one starts feeling that bumpiness if you notice that a site is starting to not respond as well, you know, you're feeling that you're needing more insulin, you're feeling that the dynamics are changing. That's I think, when it's going to be really key to make that site change. Stacey Simms 12:21 Interesting. I have kind of said, it's a little bit flippant, but I've said since we started pumping, 14 and a half years ago that gosh, these insets are the weak link in pumping. And what I mean by that is they can fall off easier, they can get occluded, they only last a couple of days. John, maybe let me ask you, can you talk us through a little bit about how you're really trying to make these better? Because I feel like I can have the greatest algorithm in the world on my pump and if the darn thing is flapping on my kids off my kids stomach it's not gonna work right back to our conversation. Yeah, he does answer that question. But first Diabetes Connections is brought to you by Gvoke Hypopen. You know low blood sugar feels horrible. You can get shaky and sweaty or even feel like you are going to pass out – there are lots of symptoms and they can be different for everyone. I'm so glad we have a different option to treat very low blood sugar: Gvoke HypoPen. It's the first autoinjector to treat very low blood sugar. Gvoke HypoPen is premixed and ready to go, with no visible needle. Before Gvoke, people needed to go through a lot of steps to get glucagon treatments ready to be used. This made emergency situations even more challenging and stressful. This is so much better and I'm grateful we have it on hand! Find out more – go to diabetes dash connections dot com and click on the Gvoke logo. Gvoke shouldn't be used in patients with pheochromocytoma or insulinoma – visit gvoke glucagon dot com slash risk. Now back to John Lindskog answering my question about making the insets more foolproof. John Lindskog 14:00 No, no, no, I totally understand what you're saying I will say and then maybe Matthias can chime in after this that, you know the products like insets, they go through a quite extensive and long development program before they actually come to the market and the products also available on basis on customer feedback. And since this is a medical device, it's very highly regulated in the US through the FDA requirements and Europe through CE and in many, many other countries through local legislation. So the level of rigor and preciseness that you have to do in this work is quite extensive for us to develop a product and mass make it into volumes, which we're talking about millions of units per year does require quite a bit of development work to go there. And there is a little bit of you know there's a lot of factors that play into to the to the development, particularly manufacturing of the infuser set, the quality has, of course, to be the highest possible within the requirements. And there's also, of course, a economical part of it, where you need the competitive cost in order to have these products on the market. So I mean, the process that you see today is actually a combination of all the the user input, and of course, also about, you know, the requirements from regulatory authorities. And, and you know, what can be made in very high scale, we, you know, and strive to improve the products along the way, however, even what may seem as being very small, and my new changes, does actually require a complete change process, which is very well documented, and in that sense, also kind of lengthy process. And I don't know Matthias. If you have any anything to add to that, yeah, quick Matthias Heschel 15:56 Yeah, but I would like to add is that we have, we have about 1 million pump users worldwide. And as a create variability, it's both the interpatient variability and intra patient variability. So huge differences between patients and also huge differences between the use conditions during a day for the same patient. So what we are going after in our product design is really making as robust designs as as reasonably possible. And best example is, is the newest infusion set on the market, which is the base of the extended wear we talked about earlier, an infusion set we call Mio advance which virtually only has one user step. So you hit the bottom activation button and it produces the soft cannula, retracts the needle and detaches the serter all instantly. I mean, all the steps happening in a fraction of a second. And that means you're basically take the patient out of the equation, the patient cannot do any mistakes during the insertion process. And there we see a huge reduction in in failures on the market. So to your question, Stacey, I mean, we understand that the infusion set is the weakest link, it's what some people call the Achilles heel. In pump therapy, we are very much aware of it. And our approach simply is, instead of doing product design at the drawing board, to the product design, in the field, really taking the patient in the core of our design process, really understanding behaviors, understanding what could go wrong, and then design the product accordingly. And we have seen the first successes and they hope to see further successes. Stacey Simms 17:40 You know, that's a great point about the very simple insertion of the Medtronic inset. Are there any plans to simplify more brands, because I'm thinking of the one we use for Tandem? And you know, by the time you open it, you peel off the sticky stuff, you, you cock it, you get it ready? You know, sometimes you're already set for error, because if the paper writes up the needle, you know, there's all sorts of different things that can happen if people either press too hard or do it at a weird angle. I know you know this, I don't have to spell it out for you. But are there plans to simplify other insets in the way that you just described? Since you've seen how successful it is? Matthias Heschel 18:16 yeah, plans to incremental improvements on existing infusion sets, based on the learnings we have from the field, among others, what we touched upon removing the paper liner from the adhesive, we can certainly redesign this to make it easier for the patient. And that's, that's definitely on our agenda. Stacey Simms 18:37 I have a bunch of questions that I got from my listeners, they were really interested that we were talking so let me go ahead and grab those. The first one here was really interesting to me. This listener wants to know about the faster acting Fiasp insulin, which seems to have a little bit of difficulty in some pumps, I was wondering if you were looking into that for different faster acting insulins that the manufacturers are coming out with and if you're testing those and working on ways to improve that in the insets Matthias Heschel 19:06 Yeah, maybe keep a close eye on the market. And every time a new insulin is approved for pumps, therapy, we add this onto our list and do all the necessary trucks stability testing, device stability testing, so you can put this onto our indication for the infusion sets and then it's up to the to the pump manufacturer to also indicate the pump for the new insulin and then the patient can use it. So and that also applies to Fiasp. So we have done all the necessary homework and we know that at least a couple of the pump manufacturers are considering to broaden their pump indication to also include the Fiasp Dr. Kerem Ozer 19:47 And to that I may also add that we're also going to be looking at Lyumjev ultra rapid lispro insulin from Lilly, which as you know is also approved just recently for pump use. So That will also go through the same processes that Matthias mentioned, whether it's working on biocompatibility, looking at what the system does to the insulin, and its excipients and what the insulin is excipients do to the pump. And so that's in the works as well. Stacey Simms 20:15 I meant to ask earlier, I had heard about something I don't know if this is the in-house name or something that you're using and research called Lantern technology. Could you explain what that is what you all are working on? Matthias Heschel 20:27 I was hoping you would ask this question. Lantern is a pretty simple feature tries to mitigate the occlusions we sometimes see for soft cannula infusion sets, when the soft cannula is bent or kinked. And the Lantern features are actually pretty simple. So we provide the soft cannula with additional slits close to the tip of the cannula, and in case the soft cannula experiences any physical impact is spent or even kinked then those slits would open up and would allow to the inset to continue to flow. So it's basically a measure to mitigate the risk that a cannula on the infusion set can get occluded in the cannula. Stacey Simms 21:15 That sounds really interesting. It sounds like didn't BD medical a few years ago have something that sounded it sounded at least to my ear similar that it had the different slits in the cannula? And it never came out? Is this similar technology. Matthias Heschel 21:29 It's you could see it as it's different as a similar technology. It's though, quite quite different. I mean, they provided an additional exit hole, just one hole close to the tip of the cannula. And that actually weakened the cannula significantly, and the product was out on the market. They call it a smart flow technology. And the product was marketed by Medtronic as a process that was withdrawn from the market right after. And with our long term technology, putting a number of slits, we have really avoiding this issue that the cannula really occludes. Imagine if you just have one side hole and the cannula kinks or bends, and you would close up this hole. And in our case, having four or six slits, that would be always a couple of slits open and allow the Insulet to flow. So it's a different technology. Stacey Simms 22:25 Yeah sure. And I don't know how much you can share which brands might get that? In other words, are you working with Medtronic on this? Or you're working with Tandem on this as somebody else? You know, in the should we be watching for this in a more proprietary form? Or will it just going to go in all of your insets? Matthias Heschel 22:40 Right now we're in the process of implementing technology in our mainstream products, which are the inset two products, which are available to all pump manufacturers, and then we need to see pump manufacturers will pick up on this. Stacey Simms 22:56 Got it. Kerem, let me ask you if I could, do you have any best practices for your patients when it comes to using the insets and infusion sets? Are there mistakes that are very common that people make, I'd love to kind of hear, you know, what you what you tell your own or in the past what you've told your own patients? Dr. Kerem Ozer 23:13 Absolutely. The key things, especially if someone is very new to living with diabetes, as you know, there's there's a lot of anxiety there. Everything is new, a lot of new information is coming in, you know, at our clinic, what I always tried to do, what we always tried to do was sort of taking a deep breath, letting people know that there's a lot of resources, there's a lot of support, you know, at the risk of sort of repeating the cliche, it's not a sprint, it's a marathon, and really providing the resources, sort of focusing that more on to the infusion set side, I think one key thing is starting, especially if someone's new to pump therapy, sitting down with them going over the whole process, we had demo kits, sometimes I would demonstrate sets on myself even just to make sure that everyone's feeling comfortable, especially for our younger patients, having the parents there and really taking the time to walk them through the process of what an ideal insertion looks like. And I think doing it in real life really helps in person in real time. As opposed to watching a video which where everything looks so perfect, right? So we definitely emphasize that prioritize that. And then when we start thinking about using the sets, a lot of those things using the alcohol pad and cleaning the area, a lot of things that are repeated, easy to say hard to do every single time. But I think emphasizing the fact that the closer and closer we get to that ideal that the longer we can keep the site's healthy, the longer we can keep the process healthy is important. And as more technology comes in as continuous glucose monitoring gets integrated. As the pumps get smarter, I think there's always the importance of that of that person factor. And making sure that we're really addressing everyone as an individual and sort of seeing where they are and going and holding their hand and walking with them to where they need to be or where they want to be, is key. And then there is as you know, a lot of variation from person to person. And there's a lot of variation from day to day. And being aware of that repeating that message. And sometimes you wake up and you have a perfect day. And sometimes you wake up and there's a lot of obstacles and changes and bringing that message that, yes, diabetes is there. Yes, it brings challenges. But if we see it as part of a larger system, and if we address it as well as we can, as if we can stick with those guidelines, and recommendations. And if we keep open lines of communication between the patient and the family and the clinic, things tend to fall into place. And I'm very proud to say your many, many patients, of course, live decades and decades of healthy lives with diabetes. And I think that the key component there is keeping those lines of communication open and keeping that sort of positive attitude going. Stacey Simms 26:38 Alright, let's get back to some of the questions that my listeners had. And I thought this was a really interesting one, she asked me when insets are designed is any consideration given to those of us who deal with limited hand strength, or older adults with smaller hands, or even using color tubing to increase the visibility of air bubbles or maybe using color in the cannula. So it'd be easier to see if it was correctly inserted. I've got to believe that you look at this and you do research it but Matthias, can I ask you to just hop in an answer that one? Matthias Heschel 27:07 Sure. Well, every time when we design a new product, we put a lot of effort into the initial conceptual work. And that means that you propose certain designs, which we then show to the target population. And if the target indication of the product is smaller children or elderly people, those will be included in the assessment of the concept. So we really trying to already in the concept phase to design the product in the way that we can make sure that it can be used by the by the target population. And at the same time, we are compliant with standards. For example, when we have a product that requires activation to push a button, what's the strength of a point of finger for a for a small girl? so we were really trying to incorporate this in our product design. Stacey Simms 28:05 Another question came in there used to be an infusion set by a different company called an Orbit. I don't recall this, but this sounds great. It rotated so the tubing was less likely to get caught. Any plans to bring that back or something similar. Matthias Heschel 28:18 Well Orbit is owned by another company Ypsomed in Switzerland, and to our knowledge, the product is still on the market. So we don't have any insights in the in the details. But it's not it's not one of our products. Stacey Simms 28:35 Got it? It's probably something that's not available in the US yet because we don't have Ypsomed here yet. But it's it's supposed to be coming. Okay, I have a very might be a silly question, but I will ask it anyway, this is a silly question. I get it from listeners all the time. One of the first times I remember getting our box of inserters we had the old one I always describe it looks like a little spaceship. I mean, I know you know exactly what I'm talking about for it was the Animas way back when and now we use Tandem, it came with these little plastic pieces, and no one ever told me what they were for. And as it turns out, then we realize this after my son's inset got filled with sand at the beach, and we could not reconnect. It turns out these little pieces are supposed to go in and protect the site and keep sand out. But I've heard a lot of different versions of what they are really supposed to do and when you are supposed to wear them. So my question is, when you put an inset on the body, it was explained to me like it's almost as though you've got like a vial of insulin with a little rubber on top. You can pierce it, but you can't get into it. In other words, you don't have to cover it every single time you take a shower or go in a pool because nothing is seeping through until you reconnect the needle. Is that the proper use of those inserters John Lindskog 29:50 Yeah, this is uh, John maybe just a quick comment. So that that is that is true that at the at the time development there were some spare caps. And the idea here was that when you disconnect the tubing from the side, it's true that you know it sealed, the side doesn't seal because there are septums that closes the fluid pathway. However, the idea about providing these small inserts was that you could protect kind of the surface of the septum. With that kind of cover so that you wouldn't have any kind of larger particles being able to, to come in the way like the listener just described getting sand in it. So it was actually, you know, kind of a protection. However, it was not something which was necessary, it was kind of, you know, choice you could make to add that in, though. So that the reason behind that Stacey Simms 30:48 perfect, there just seems to be a little bit of a misunderstanding in some parts of the community, what people think it keeps bacteria from getting, in other words, if you swim in a lake or something like that, you should pop it in. But it really is just to keep out particles like sand. John Lindskog 31:01 Yeah, it's only for larger particles. And, you know, the site is perfectly sealed as it is. So it's it's more to kind of say, Okay, I want to make sure that that, you know, I don't have to clean it up afterwards, and so on. So that was the rationale behind that. Stacey Simms 31:18 I have one or two more questions, kind of to wrap it up. Have I missed anything in particular that you guys wanted to make sure to bring up before I start wrapping up? John Lindskog 31:26 Actually, there was just one question that I think that at least I had, I would be curious to know about, you know, in each box of the insets, there is an instructions for use, how you deploy, the infusion set. What's out and, you know, that is in some countries made in a number of different languages and so on. And I guess I'm just curious about is that being read all the time, or is that you know, being kept in the place or simply just, you know, put it into the trash can. But what's kind of, because I have a I have an assumption. We have an assumption, what happens to these but but I was just curious to know, if you could share that with us. Stacey Simms 32:07 I'm so excited that you asked that question, John, I think you know the answer, I can't imagine anyone is really reading the instructions, we all should. In fact, I'm going to take those instructions out and look through them. But it's one of those situations where my book that comes with each box is so thick and intimidating. As I'm telling you this, I'm thinking this is why I don't do it, maybe it's just I'll have to take a look at how long the actual instructions are. Maybe it's in several languages. And that's why it's so thick, but we're so used to and maybe we can blame the iPhone for this. We're so used to opening something up and being able to use it immediately and hoping right that it's very intuitive, that maybe that's why we don't read the instructions. So there's a lot of user error. And frankly, I know there's a lot of user error within sets. I've seen it in my house, I've been the user making the error. So I'll ask my listeners, I mean, I'd be happy to take a quick poll in the Diabetes Connections Facebook group, but I do recall taking a pump class, and we were there for two hours, I came home a couple of days later, I had to change the inset on my two year old I had forgotten everything I had learned. And at the time, this was 2007. I found one video, I mean, think about the days of YouTube back in 2007. And it was in French to show me how to change the inset. But I did that rather than look for the instructions. So John, what a great question. And I will get you more feedback from the community on that. John Lindskog 33:29 Okay, thanks. Thanks a lot. Thanks. I will say though, that, you know, it is a regulatory requirement that we put those in a box. And we would, you know, like to move it into some kind of, you know, YouTube media or something like that. However, the regulatory requirements are that they should always be there. So we want to see if we can move that in the regulatory requirements. So we can, you know, save some printed matter, and, you know, reduce the waste and make it easier to access. Stacey Simms 34:02 It's a great point. That is a great point. Before I let you go, here in the United States and I assume in many parts of the world, there's a lot of concerns about supply right now. Any issues, any concerns anything people should be thinking about for the next couple of months? John Lindskog 34:16 No, I you know, and we have had some issues on supplies in the beginning of the when COVID-19 was at the highest and we have been putting in extra capacity for making progress and investing large sums of money into getting you know, capacity brought up and we should be out of those weeds by the end of this year. And we don't really see any, any issues going forward. But you know, it may take some time to get that all through the supply chain, but I can assure you that we're doing everything which is now a power to always have the capacity to supply the what the demand is. Stacey Simms 34:57 Let me as we wrap this up, Kerem, let me ask you this. You are new to the company, or you are the newest person here, so the company, what excites you and you know, you've worked with patients for a long time, you've seen how important this part of the device and system is, what excites you about this technology going forward? Dr. Kerem Ozer 35:15 This is a great question. And this is the reason I'm, I'm here, I'm in the company, I think it really goes back to that point about realizing how important looking at patients insights, their experiences, where they are, what they need, and bring that feedback into the company to help develop new technologies. And I would say, a direct corollary to why I'm so excited about my role here is this is really sort of being a medical person, a physician, and endocrinologist and industry, you really play a bridge role. You're constantly talking with the engineers with the business side, and you're keeping your ear open to your patients, your community and your colleagues. And sort of you're part of that feedback loop, bringing back ideas, presenting your products and saying this will work. This is a great idea, and sort of keeping that momentum going. And I'm very excited about that. Stacey Simms 36:20 Excellent Matthias you are in r&d, you are the head of r&d, you're in the I wouldn't say the trenches so much. But you're really seeing realistically what's happening on the company every day. Anything you want to add to that. I mean, is there anything that you're really excited about that you'd like to listeners to leave listeners with? Yeah, Matthias Heschel 36:37 I mean, what, what I always tell the engineers is, you guys, you are directly responsible for how patients or people in the state beat is, how they feel how they are able to manage their daily life. If we do a great job, those people can lean back once in a while and perhaps even forget about the disease, if it will not do a perfect job. They have a terrible day. So that's, that's really what people understand. And that's why at least how I see it. I mean, those people in the medical device industry typically work longer work harder, because they understand they understand the responsibility they have. Stacey Simms 37:17 Well, thank you so much all of you for spending so much time with me for answering our questions for posing your own questions, which doesn't happen that often. And I'm really glad that you did that. We will get you some answers. Thanks so much, gentlemen. You're listening to Diabetes Connections with Stacey Simms. Lots more information at diabetes connections.com at the episode homepage, and I'll link to some of the studies they talked about that longer were the stuff that's in the works. And let me tell you, I went and got the book. I have it right here. Can you hear that? I'm wiggling it, I went and got the book that comes with the insets. And it's right there. Of course, at the top with the little horseshoe thingies that they explained. I hope they cleared up some stuff for you. The book is long, because as I said, it's in many other languages other than English, the directions are maybe two or three pages long. I think it's really just two pages. There's some pictures here. But the English instructions are one to three pages long. And then that's it. So Benny and I actually sat down and read them. And he does it slightly differently. But what he does works, I mean, we are 15 years into diabetes. So that means we were 14 and a half years into pumping. So he's got it down. But if you're having trouble, I may start a thread in the Facebook group. Because there's some really easy tips and techniques to make sure that you you put these insets on correctly in follow the directions. That's your best bet. But as you know, the community can help too. So we'll we'll put that in there. And of course, I'm going to put a poll up about the and we put I may have already done that by the time the episode airs, because a pull up about have you ever read the directions? I was a little embarrassed. You heard me laughing when he asked, but I'm glad he did. Alright, I've got some news coming up about next year. Oh my gosh. But first Diabetes Connections is brought to you by Dexcom. And when we first started with Dexcom, it was back in 2013. It was about this time here, the share and follow apps were not an option. They just hadn't come out with the technology yet. So trust me when I say using share and follow make a big difference. I think it's important though to talk to the person you're following or sharing with and get comfortable with how you want everyone to use the system. Even if you're following your young child. These are great conversations to have, you know what numbers will make you text, write how long you're going to wait to call that sort of thing. That way the whole system gives everyone real peace of mind. I'll tell you what I absolutely love about Dexcom share and that is helping Benny with any issues using the data from the whole day night. And not just one moment. Internet connectivity is required to access separate Dexcom follow up to learn more, go to diabetes connections.com and click on the Dexcom logo. A couple of weeks ago I told you I would have some book news and I do I am so excited to announce that the world's worst diabetes mom, part two is going to be out next year, I just signed on with my publisher. We talked this week, actually this morning, as I'm taping this episode, and we laid it all out, because my goodness, with some of the publishing issues, probably hopefully not the shipping issues by next year. But a lot of what's going out of the publishing industry, I have to have everything done earlier than I did last time to have the book Ready by a certain time of year I wanted out for as you can imagine, I wanted for November of next year, because Diabetes Awareness Month is my best bet to get any kind of, I guess, mainstream media attention on diabetes, media attention. And that worked really well. In 2019. When I put out the first book, the name of the book is not part two. I'm not sure what we're going to call it yet. But I will be sharing that with you all, I'm going to be sharing more of the process this time around, just as I think it'll be fun. And I'm going to be sharing things like cover options and title options in the Facebook group Diabetes Connections, the group. So if you'd like to help me the community was a huge help last time around in terms of how to word things. Because you know, when you're a parent of a child with type one, there are some differences that you want to be respectful about. There's some differences and ways of wording things that that just for clarity, right? A good example is are you a T one D parent, to me, that means a parent who lives with type one, right? So you have to It's little things like that you just have to be careful about and you will help me so much with that the first time around. So I will be asking the second time around, I have an idea for a title, I kind of know what the direction is going to be. I know what the title is going to be. I know what the focus is going to be on. We're going to be addressing a lot of the things that I have been asked about since the first one came out. So really excited, a little bit nervous. But man, I loved writing the first one. So I hope this will be as much fun to put together. All right, thank you so much to my editor John Buchenas from Audio Editing Solutions. We will be back on Wednesday. We are now live on Facebook and YouTube at 430. Eastern time. And then around 445 I'm live on Instagram. A little bit different for those of you who live on Instagram a lot like evolve. I mean, what a pain. Right? But it's fun. I like doing it. It's only a pain because I share photos. And I'm not that adept. Really. I mean, Instagram is not a friendly platform for sharing photos live and reading a script. Let me just tell you say if you've got advice on that, and you know how to do it, well, let me know. Or you could just listen to the audio podcast that comes out every Friday for in the news. Thank you so much for listening. I'm Stacey Simms. I'll see you back here soon Until then be kind to yourself. Benny 42:35 Diabetes Connections is a production of Stacey Simms media. All rights reserved. All wrongs avenged

In the News.. oral insulin tested for T1D, FDA looks at new tubeless pump, Bigfoot Clinic Hub & more!

Diabetes Connections with Stacey Simms Type 1 Diabetes

Play Episode Listen Later Dec 3, 2021 6:16

It's "In the News..." the only diabetes newscast. Top stories this week include: #T1D oral insulin study moves ahead, FDA gives breakthrough designation to new SIGI tubeless pump, study shines light on PBM profits, China demands huge drop in insulin prices and Bigfoot Biomedical launches their Clinic Hub -- Join us LIVE every Wednesday at 4:30pm EST Check out Stacey's book: The World's Worst Diabetes Mom! Join the Diabetes Connections Facebook Group! Sign up for our newsletter here ----- Use this link to get one free download and one free month of Audible, available to Diabetes Connections listeners! ----- Get the App and listen to Diabetes Connections wherever you go! Episode transcription below: Click here for iPhone Click here for Android Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and these are the top diabetes stories and headlines of the past seven days. As always, I'm going to link up my sources in the Facebook comments – where we are live – we are also Live on YouTube and in the show notes at d-c dot com when this airs as a podcast.. XX In the News is brought to you by The World's Worst Diabetes Mom, Real life stories of raising a child with diabetes. Winner of the American Book Fest Prize for best new non-fiction. Available in paperback, on Kindle or as an audio book – all at Amazon.com. You can also get a big discount right now at diabetes-connections.com – use promo code celebrate to save $4 XX Our top story this week.. More good news for mice.. and maybe some day for people. Yale researchers are looking at an oral medication for type 1 diabetes. These lucky mice had metabolic function restored and inflammation reversed. There are a lot of studies going on to make oral insulin work – liquid insulin is destroyed in the stomach before it hits the bloodstream. This research involves a nanoparticle drug vehicle that can not only bring insulin to the pancreas safely, but the casing itself has therapeutic benefits. It's made out of an acid that seems to reduce the rogue immune cells that destroy the beta cells in the first place. The team says that the nanoparticles could also be used to carry other molecules, which could help with other conditions. https://newatlas.com/medical/oral-insulin-pill-prevents-type-1-diabetes/ XX A new tubeless pump is making its way through the US regulatory process. The FDA gives breakthrough device designation to AMF Medical's Sigi (SIG-ee) Insulin Management System. This is a patch pump, like Omnipod, but it's rechargeable and re-usable – you get two so you don't have to go without while it's charging. It's also an ACE pump, that's alternate control enabled which means it can interact with CGMs and controller devices like smartphones. This designation isn't FDA approval, but it should speed up the review. In the press release the company says, “Clinical study data has shown that Sigi™ is delightfully easy to use.” Which is kind of a nice thing to see in a write up like this. https://sigipump.com/amf-medical-receives-fda-breakthrough-device-designation-nbspfor-its-sigi-insulin-management-system/ XX Big news from the UK this week – they announced everyone in England with type 1 will be eligible for CGMs covered by the National Health Service there. This was preceeded by coverage for the Libre flash glucose monitor. That program was supposed to start at 20% but almost 50% of people with type 1 have opted in and the results in terms of better health and lower a1cs have really been outstanding. Next up, leaders there say they want CGM covered for anyone using insulin, regardless of diabetes type. https://pharmaceutical-journal.com/article/news/nice-proposes-wider-use-of-glucose-monitoring-devices-for-type-1-diabetes XX New research into insulin pricing is shining a light on the middle men.. many of us have known about PBMs for a long time. Researchers at USC found that drugmakers' share of revenue from insulin sales has dropped in recent years — and a greater share is being siphoned off by pharmacy benefit managers, drugstores, wholesalers and insurers. In 2014, 30% of insulin revenue went to PBMs. By 2018, those same middlemen were receiving 53%. Terrific write up as usual by David Lazurs in the LA Times – he lives with type 1 and I always love his stuff. I'll link this one up. The researchers here say since the PBMs are getting a greater share, there's pressure on the drug's manufacturers to keep raising prices so their own profits don't suffer. It's worth noting that these findings were possible because of newer state laws bringing greater transparency to insulin sales. https://www.latimes.com/business/story/2021-11-30/lazarus-healthcare-insulin-prices XX What works to bring down the price of insulin? Ask China. They decided a round of price cuts is due and as a result, 42 insulin products from companies in China and abroad took an average 48% price drop. Otherwise, they wouldn't have been used in that country's public hospitals. Lilly gave up the largest discount: After a 75% reduction, the price of Humalog went down to about $3 per pen. China has been making pharma cut prices for the last few years for other medications. This is the first time insulin has really been affected. https://www.fiercepharma.com/pharma-asia/novo-nordisk-sanofi-eli-lilly-cut-insulin-price-china-s-latest-vbp-off-patent-drugs XX Bigfoot releases some information and reaction to their Clinic Hub. This is how endos and clinics use the data from the Bigfoot Unity System to support patients. Unity launched this summer – it's their smart pen program. When you think about multiple daily injections whether it's for type 1 or type 2.. it's hard for health care providers to see what's going on day to day.. are doses correct, when they're giving, etc. Unity can also include CGM data. This is the launch phase of Clinic Hub.. Bigfoot says they've also added streamlined patient onboarding and more flexibility for patient updates and prescription management. https://www.drugdeliverybusiness.com/bigfoot-biomedical-touts-cloud-based-program-for-managing-diabetes/ XX I'm including the Vertex news here.. we reported this back in October but you probably had everyone you know send you that New York Times article about a cure for type 1 – at least in one guy.. I won't rehash everything here.. it's about stem cells, one patient off insulin but on immunosuppressive drugs.. Personally, I'm very hopeful, but the Times write up overly simplified a lot of this, in my opinion. Good write up in Healthline that I'll link to. https://www.healthline.com/diabetesmine/vertex-type-1-diabetes-research XX In the UK lots of attention on their Strictly Come Dancing competition… when it became apparent contestant Nikita Kuzmin wasn't hiding the Libra glucose monitor on his arm. He wasn't hiding much.. he took off his shirt for this performance. Loads of social media comments applauding him.. for both. By the way, his dance partner, Tilly Ramsey is the daughter of professional chef Gordon Ramsey.. and they were eliminated from the show this round. https://www.express.co.uk/life-style/health/1528577/strictly-come-dancing-nikita-kuzmin-health-diabetes-type-1-symptoms -- quick reminder that the podcast this week is with the UK co-lead on diabetes, Dr Partha Kar. We had a great chat about access and their Libre program and his whole philosophy.. really fun episode. Next week you'll hear from the folks at ConvaTec, they make almost all the pump insets and they have some great info for us all. you can listen to wherever you get your podcasts or if you're listening to this as on a podcast app, just go back an episode. That's In the News for this week.. if you like it, please share it! Thanks for joining me! See you back here soon.

183 - Dr Frances Henshaw WOUND MANAGEMENT

Podiatry Legends Podcast

Play Episode Listen Later Dec 3, 2021 41:57

Dr Frances Henshaw from ConvaTec is an experienced podiatric clinician, researcher and scientist. She recently jumped the fence into the corporate world, where she is passionate about raising the bar and making wound education interesting, accessible and fun. The overarching theme of her PhD research has been understanding mechanisms of foot ulceration so that targeted prevention and treatments can be developed. Frances has over 15 years of experience as a business owner, 20 years as a clinician and more than ten years as an academic at Western Sydney University. "With good care, the wound will heal". Big Tip Wounds don't heal quickly, so stop second-guessing yourself. You could ask four different podiatrists about how they would treat a wound, and you will get four different answers, and they're probably all right. If you want to ask Frances any questions, you can email her at frances.henshaw@convatec.com. Her podcast is called The Wound Doctors. If you have any questions or want to learn more about how I can help grow your business, please call me on 0408 671 966, send me an email at tf@tysonfranklin.com; otherwise, you can go directly to my online calendar and schedule a face-to-face Zoom meeting with me. ONLINE CALENDAR Youtube I record and upload most of my podcast interviews and other educational videos to my Youtube channel, Tyson E Franklin - Podiatry Business Coach. Please SUBSCRIBE, and if you click on the bell icon, you'll be informed whenever a new video is uploaded. Competitive Advantage If you're looking for a competitive advantage over other podiatrists in your area, please visit my EVENTS PAGE, and consider joining the Podiatry Business Owners Club on Facebook.

phd zoom feet wound ulcers western sydney university podiatry henshaw wound management convatec events page

David Pudwill- Reg Affairs expert- What companies & professionals get wrong about Reg Affairs

The Med-Tech Talent Lab

Play Episode Listen Later Jul 23, 2021 47:30

I was joined by Mr. David Pudwill, a Regulatory Affairs expert for both medical devices as well as combination products.David holds a Bachelor's Degree in Biomedical Engineering and his Masters in Mechanical Engineering. David actually spent 9 years of his career working directly for the FDA as a lead medical device reviewer. After that he spent several years with a med-tech organization called Convatec where he was responsible for developing and growing Global Regulatory and Quality teams as large as a hundred people worldwide, while developing new ways of thinking about Regulatory Affairs for both in market support as well as new product development and a digital transformation.David currently runs a consulting/educational based firm called Mr. Regulatory. The organization really started as an educational platform primarily discussing all things regulatory, guidance documents, things like that on his Youtube channel. He is in the process of growing the content on that channel, but he is also providing consulting services to a variety of start up organizations across the med-tech space when it comes to Regulatory strategy and he is really helping organizations primarily who don't yet have a regulatory in house force be able to define the right path and gain access to the market.During our conversation, David and I discussed his experiences with the FDA as well as how he decided to start his own show vs working for another organization.Some key highlights we discussed:-What did working for the FDA teach him that was beneficial for working in-industry-What mistakes did he make as a leader that he learned from and is better off because of-What do companies get wrong about Regulatory Affairs? (timing, importance of the function, submission documentation, etc)-What mistakes does he see up and comers, who are striving to be promoted, making along their journey?...and so much more

masters bachelor companies degree fda professionals affairs regulatory mechanical engineering biomedical engineering regulatory affairs convatec

Gamechangers LIVE featuring Symeria Hudson

Gamechangers LIVE with Sergio Tigera

Play Episode Listen Later Jul 8, 2021 33:29

As president and CEO of Chapman Partnership Symeria oversees the strategic, programmatic, financial, and managerial operations of the organization in support of its mission and vision. With more than 20 years of experience, she has held key executive roles leading large-scale franchises, product portfolios, and driving product innovations for top medical technology and healthcare companies in the U.S. and Europe. During her time in the medtech/healthcare industry, she was responsible for global marketing including strategy, commercial excellence, portfolio management and research and development. In 2016, she helped drive ConvaTec's flotation on the London Stock Market, the largest IPO by a healthcare company in Europe. In 2015, she was named a Top 50 Business Leader of Color by Chicago United Organization, she served as a board member of the Kohl Children's Museum and the Baxter Foundation. She earned an MBA from Harvard Business School and a bachelor's of science from Alabama A&M University School of Business.

ceo europe business mba color museum game changers ipo harvard business school business leaders m university school convatec

Interview with Angie Christopher: Take Risks

Strata Leadership Show

Play Episode Listen Later May 7, 2021 20:06

Angie currently serves as Vice President for Global HR and Talent for the Home Services Group for ConvaTec. Her career with the organization started nearly four years ago and in that short span, the company has more than doubled its number of employees across two continents. Angie is a die-heart sooner fan with two degrees from OU including a Doctorate of Law.She practiced for several years as in-house counsel for Oklahoma Farm Bureau then started her HR journey there in 2002 as VP of HR. HR has been the perfect fit for Angie’s passion for mentoring and strategic thinking.Along with HR, Angie is active in several non-profit organizations including serving on the boards for the Urban League of Greater Oklahoma City and Guiding Right and volunteering whenever the opportunity arises.In 2000, she founded Diamond Daughters, LLC. An organization designed and focusing on mentoring young women. This group has seen nearly 300 girls pass through its doors with two currently serving on its Board with their doctorate degrees.In her spare time, Angie is rediscovering traveling to historical sites, spending time with her 18-month-old godson, and crafting.

law coaching vice president board positive talent llc doctorate leadership development take risks urban league inspiring people global hr convatec oklahoma farm bureau

David Johnson, Chairman and CEO of Enveric Biosciences

Green Rush Podcast

Play Episode Listen Later Mar 25, 2021 32:27

This week on The Green Rush, our hosts Nick and Anne are chatting with David Johnson, CEO of Enveric Biosciences, a patient-first biotechnology company developing rigorously tested, novel cannabinoid medicines to improve quality of life for cancer patients. It’s been a while since the Green Rush team has talked about CBD so we used this opportunity to get an update on the state of the space including how CBD is fitting into the existing medical landscape, the ways that technology is progressing the validation of these molecules and what the market could look like in the next several years. We also explore Enveric’s business model and how they compare to other players in the industry as well as key news from the industry including Jazz Pharmaceuticals acquisition of GW Pharma. Now on to our conversation with David Johnson of Enveric Biosciences. David Johnson, Chairman and CEO of Enveric Biosciences Former CEO of Convatec, oversaw the $4.1B spin out of Convatec from Bristol Myers Squibb; former CEO of Alliqua Biomedical, a developer of wound care technologies. Links and mentions in the show https://www.enveric.com/ Diverse Biotech PartnershipPureForm Partnership Links to the guest’s company and social media accounts David Johnson’s LinkedIn: https://www.linkedin.com/in/david-johnson-235b0224/ Show Credits: This episode was hosted by Anne Donohoe and Nick Opich of KCSA Strategic Communications. Special thanks to our Program Director Shea Gunther. You can learn more about how KCSA Cannabis can help your cannabiz by visiting www.kcsa-cannabis.com or emailing greenrush@kcsa.com. You can also connect with us via our social channels: Twitter: @The_GreenRush Instagram: @thegreenrush_podcast LinkedIn: https://www.linkedin.com/company/thegreenrushpodcast/ Facebook: https://www.facebook.com/TheGreenRushPodcast/ YouTube: https://www.youtube.com/channel/UCuEQkvdjpUnPyhF59wxseqw?disable_polymer=true

ceo cbd 1b david johnson bioscience bristol myers squibb green rush jazz pharmaceuticals convatec gw pharma

How will Emergency Use Authorization (EUA) during Pandemic Influence Future FDA Policy Changes?

Global Medical Device Podcast powered by Greenlight Guru

Play Episode Listen Later Dec 9, 2020 39:17

Still seeking guidance to stay in the know when it comes to new and updated FDA requirements related to medical devices, especially during the ongoing pandemic? In this episode of the Global Medical Device Podcast, Jon Speer talks to David Pudwill, senior director of regulatory affairs at ConvaTec and industry thought leader who has been coined the name “Mr. Regulatory.” Listen to this episode as Mr. Regulatory shares his predictions on potential policy changes or updates we may begin to see from FDA, as influenced by the Emergency Use Authorization (EUA) response to address the current health crisis caused by the COVID-19 pandemic.

covid-19 pandemic influence policy emergency fda regulatory authorization emergency use authorization eua convatec

6. Parastomal bulges: identification and management

GINcast: the Gastrointestinal Nursing Podcast

Play Episode Listen Later Dec 1, 2020 32:56

Wendy Osborne, Clinical Lead at Coloplast, speaks with Amanda Gunning, Lead Stoma Care Nurse at the Royal Devon and Exeter Hospital NHS Trust, about outward body profiles in people with an ostomy, covering the causes and impacts of parastomal bulges and hernias. They explain how stoma care nurses can help ostomates minimise the risk of hernia occurrence, as well as, should one occur, how it can be effectively assessed and managed to improve the patient's comfort and quality of life. This episode is sponsored by Coloplast and ConvaTec.

management identification clinical lead stoma colostomy ostomy ileostomy coloplast ernia convatec

#33

The Human Performance Podcast

Play Episode Listen Later Oct 28, 2020 39:16

On the podcast this week is Dr Jonathan Sackier, MB, ChB, FRCS, FACS who is an internationally renowned surgeon, technology innovator and entrepreneur. Trained in Britain as a surgeon and recruited to the USA in 1989 he helped lead the laparoscopic surgery revolution. As a Professor at George Washington University in Washington, DC, he founded, and funded the Washington Institute of Surgical Endoscopy, a center for education, research & innovation. He is a Visiting Professor of Medicine & Surgery at the University of Virginia and his activities in basic and clinical research funded by multiple grants have led to many publications, chapters and books. He has served multiple journals as editor or reviewer, has been involved in medical societies at the highest level and has been honored for his work in many countries. Jonathan's collaborations with the pharmaceutical and medical device industry have resulted in technologies that have been brought to market with partners like Valleylab, Pfizer, Karl Storz, Applied Medical and Pall. In 1984 his team at Genethics discovered and patented a line of amniotic stem cells and then licensed the rights to a publicly traded British drug discovery company. He helped develop and bring to market the AESOP robot with Computer Motion, who had a successful IPO in 1997 and has also started a medical products contract sales organization, a locum medical agency and a communications company. He has consulted to many companies including Aventis, Cook, Integra Neurosciences, Bayer, Cryocath, Novartis and ConvaTec and has worked with the financial community on enterprise financing, mergers & acquisitions and due diligence. A frequent commentator in the media, Jonathan has been a guest on radio and television many times to discuss various healthcare issues. In the mid-1990's he hosted a television health magazine program “Health and Wellness” aimed at a senior audience for the Goodlife Cable TV network and served the communications company Spotlight Health with their celebrity featured outreach including the hugely successful Carnie Wilson web-cast which drove increased attention to bariatric surgery as an option for the management of morbid obesity. Jonathan has served the National Committee of the Steppenwolf Foundation, is a Trustee of the First Star Foundation, the Virginia Hillel Board and previously chaired the Board of the Larry King Cardiac Foundation. He has sat on the Associate Board of AdvaMed (the medical device industry trade association) and on several corporate and scientific advisory boards.

Medical Device Design & Sustainability w Julie Lambrethsen R&D Director @ Convatec - Season 1 Episode 10

Design Truth

Play Episode Listen Later Aug 27, 2020 73:32

So here is episode 10 of our podcast. We have had a boat load of views over the last few weeks, and have found ourselves on the design charts so THANK YOU.There is a slight audio issue with this particular episode. With zoom and digital tools, sometimes these things happen. Drew has done an awesome job with the edit to get this listenable.Julie is the R&D director over at Convatec which is a global medical product and technology business with a particular focus around wound and skin care, ostomy care, continence and critical care and infusion devices.We spoke about medical device design in lockdown. The harsher realities of sustainability. The agency/client dynamic and how to get the best out of that relationship.To be involved in the podcast, or to speak at our live events, send us a message to hello@designtruth.co.ukwww.designtruth.co.ukInstagram: wespeakdesigntruth

design sustainability medical devices d director convatec

Gutless to Grateful #lovemydetour with Amy Oestreicher

The Empowered Spirit Show

Play Episode Listen Later Aug 1, 2020 56:17

As this podcast goes to air we are moving into our next full moon. The sun sign is in Leo and the moon is full in Aquarius… a reflective time time to nourish our creations and break through our limitations. Aquarius energy teaches us to break free of our limitation and the social norms to find our true self. The vibrations coming in now are all about breaking free and finding new perspectives. And as we have been talking about... this full moon is allowing each of us to open up fully to our light… to that part that inspires us to go beyond... to heal our wounds... to know that we are all evolving - evolution - revolution. It is also about questioning your own consciousness and where each of us can awaken… individually and collectively. This full moon asks you to feel your truth and then send it back out into the consciousness around you to help share a new reality. Aquarius and Leo energy encourages us to know where we are and insures us to shed expectation from others, to rise above the fear of rejection and align with our essence. When you can reframe your challenges and problems as portals of energy… ways to illuminate the lessons rather than as just limitations, you open yourself up to discover the immense power you hold within yourself to heal and let go of your emotional blocks. All of this I talk about about on the Energy Focus of the week which you can find live on Sunday nights on Facebook or Instagram. Download my free guide to help you set up your own daily Practice. You can find it on my website at TerriAnnHeiman.com. Or if you would prefer some private help, join me in my Empowered Spirit Program. Schedule an Empowered Spirit Discovery Session with me and let's discover what three things are draining you of your energy and if this program is a fit for you. I am seeing clients, virtually and some in person, and I do have just a few spot left for my private mentoring program . In today's episode, I talk with Amy Oestreicher about her life, her challenges and especially her creativity and how it has helped her to overcome her obstacles. Her book, My Beautiful Detour, is one of the most inspiriting story I've heard in a long time. I absolutely fell in love with her! We talk about creating and art as a means to heal, detours, resilience, abuse, PTSD, eating and so much more that went into her own personal healing. Talk about reframing your challenges and problems... wow. Amy Oestreicher is a PTSD Specialist, Audie award-nominated playwright, performer and multidisciplinary creator. Amy overcame a decade of trauma to become a sought-after traumainformed teaching artist, author, writer for The Huffington Post, international keynote speaker, RAINN representative and health advocate. She has given three TEDx Talks on transforming trauma through creativity, and her story has appeared on NBC's Today, CBS, Cosmopolitan, Seventeen Magazine, The Washington Post, Good Housekeeping and MSNBC, among others. A singer, librettist and visual mixed media artist, she dedicates her work to celebrating everyday miracles, untold stories and the detours in life that can spark connection and transform communities. Amy has toured her autobiographical musical, Gutless & Grateful, to over 200 venues from 54 Below to Barrington Stage Company since its 2012 NYC debut, as well as a mental health program for colleges, conferences and organizations. She is currently developing her full-length play, Flicker and a Firestarter, which just had its first AEA Staged Reading, and More Than Ever Now, a play based on her grandmother's story of survival. She most recently premiered her one-woman multimedia musical, Passageways, at HERE Arts Center, for which she created music, book, lyrics and artwork. As the 2014 Eastern Regional Recipient of Convatec's Great Comebacks Award and WEGO Health “Health Activist Hero” and WeGO Health Expert, she speaks for National WOCN conferences and the American College of Surgeons Clinical Congress and writes for the official print publication of the UOAA. She has devised programming for the Transformative Language Arts Network National Conference, the Eating Recovery Foundation, the 40th Anniversary New England Educational Opportunity Association Milestones Conference, three Annual National Mental Health America Conference and others. She has been the featured keynote speaker for national conferences including the Pacific Rim Conference of Diversity and Disability, the International School of Social Work Conference and Women of Resilience. As a playwright, Amy has received awards and accolades for engaging her audiences in dynamic conversation on trauma's effects on society, including Women Around Town's “Women to Celebrate” 2014, BroadwayWorld “Best Theatre Debut,” Bistro Awards “New York Top Pick” and the “Singular Award” at the Sarasolo Theatre Festival, presented annually for a “performance that is exceptionally uncommon, groundbreaking, original and inventive.” Amy has performed excerpts of her solo oral history play, Divers, as part of Brooklyn's immigrants and Exile, Beechwood Art's Giving Voice, Dixon Place, Seekonk Storytelling Television Special, and Museum of Jewish Heritage Festival of Untold Women. She is a cabaret and theatre reviewer for BroadwayWorld, Her theatre education essays and monologues have been published in Creative Pedagogy journals, as part of a theatre curriculum for high school students in the Philippines. Her play, "We Re-Member" honoring the immigration stories of her grandparents, has been performed in twelve states, and her full-length play, Factory Treasure, has been performed at the Philadelphia Arts Center, Identity Theatre, LIU, The Depot and Actors Theatre of Newburyport. Her short plays have been published by the Eddy Theatre Company and finalists in Manhattan Repertory Theatre's Short Play Festival, as well as NYC Playwright's Women in the Age of Trump. Amy's collaboration with Beechwood Arts on the immersion salon, “Resilience and the Power of the Human Spirit,” has traveled around the world to health and arts facilities as a public installation, incorporating her monologues, art, writing and recipes to express the life-altering detours and ultimately the invaluable gifts of her resilient journey. Amy is also an active artist and teacher in the Jewish community, being honored by United Way in 2005 for her music programs at Hollander House, completing artist residencies at Art Kibbutz, and delivering “Hope, Resilience & Biblical Women” keynotes for synagogues and religious schools. She is a teaching artist with Brooklyn's Community World Project, and trained ACTSmart, a Playback Theatre troupe in Amherst, MA. She is also a passionate arts education advocate, a successful mixed media visual artist, a continuing education studio arts teacher and her artwork has been shown in esteemed galleries in Massachusetts, Connecticut, Chicago, San Diego and New York, as well as published in national publications including Conquer, Topology and Cargo Literary. She has recently published her memoir, My Beautiful Detour: An Unthinkable Journey from Gutless to Grateful. See more at www.amyoes.com. Facebook. Instagram. YouTube #lovemydetour Join The Campaign. Walk - “Step into Joy” Step Into Joy Workshops: Walking for Connection, Discovery & Play Covid masks - Art stuff - TedXTalks. Sexual trauma of my PTSD: It's OK to Freeze: Healing From Sexual Assault Spiritual Ecology: The Cry of the Earth As Amy says… we are have this creative force within us. Allow yourself to go within and find this energy to help overcome any obstacle. Reach out to Amy for inspiration, her programs or to bring her to your group and have her share her inspiring story. I fell in love with her. #Lovemydetour - be a part of the movement! And, if you need help on your spiritual path, reach out to me. I have a few openings for my private mentoring program. Thanks again for listening. To your Spirit, Terri PS… Schedule a Virtual Coffee here. Join Terri's Facebook Group Follow Terri on Instagram Find her on LinkedIn EPISODE CREDITS If you like this podcast and are thinking of creating your own, consider talking to my producer, Danny Ozment. He helps thought leaders, influencers, executives, HR professionals, recruiters, lawyers, realtors, bloggers, coaches, and authors create, launch, and produce podcasts that grow their business and impact the world. Find out more at https://emeraldcitypro.com

covid-19 women new york new york city chicago donald trump art power spirit talk practice reach diversity san diego jewish resilience celebrate ptsd massachusetts nbc cbs museum washington post connecticut sexual philippines grateful huffington post disability exile conquer msnbc american colleges cosmopolitan aquarius tedx talks divers united way amherst liu firestarter depot good housekeeping rainn international school human spirit flicker giving voice broadwayworld newburyport seventeen magazine gutless topology dixon place energy focus actors theatre passageways danny ozment amy oestreicher barrington stage company playback theatre here arts center convatec lovemydetour manhattan repertory theatre my beautiful detour gutless grateful ptsd it

The challenges that a stoma brings

The FitPro Podcast

Play Episode Listen Later Jun 19, 2020 25:42

In 2010, Sarah Russell was rushed into hospital with abdominal pain, given major surgery and ended up with a stoma. Here, she speaks to Jane Waller about her journey, the challenges she has overcome to train for marathons and how she is now educating healthcare and fitness professionals on how they can help clients who experience similar challenges. For more information: Me+recovery by ConvaTec http://bit.ly/32lDWFR PT's can call and get a pack sent to them and also encourage patients to register for the free pack/exercise programme Sarah's book available to buy from here https://amzn.to/38LPnJu

challenges stoma sarah russell convatec

EL CAMINO A LA FELICIDAD INTEGRAL DEL LÍDER CONSCIENTE DE SÍ MISMO

YOEMPRESARIO, Mi Vida es Mi Empresa.

Play Episode Listen Later May 16, 2020 24:15

Descubriendo quiénes somos, por qué y para qué estamos haciendo el viaje de la vida, identificando cómo podemos cumplir con nuestra misión de vida sobre la tierra desempeñando roles físicos, emocionales, sociales y espirituales de manera integral para experimentar la felicidad integral como líderes conscientes de nosotros mismos. JACINTO SENCION MATEO hizo la entrevista en su programa de TV "Voz para el Cambio", por Telecanal 28, a FRANCISCO YULI, Director General y Fundador de www.fundcioncedi.org, (CEDI), Conferencista, CEO de AYACAM. Productor y Conductor del Programa Emprendimiento Juvenil, Jueves 5-6pm., Radio Juventus Don Bosco. Productor y Conductor Segmento YO EMPRESARIO TV, Telecanal 28, Martes 6:30pm. a 7:00pm. Certificado y Reconocido por instituciones de Estados Unidos, México, Guatemala, Europa y República Dominicana formador de Líderes Emprendedores. Co-propulsor y Director de Programas de Formación de Lideres Juveniles Emprendedores JA por 13 años. Certificado de la Universidad de País Vasco, España en Derecho Internacional y Relaciones Internacionales. Magister en Derecho y Relaciones Internacionales, Universidad Autónoma de Santo Domingo. Certificado en Gerencia, Motivación y Supervisión de los Recursos Humanos, Universidad Pedro Henriquez Ureña (UNPHU), Lic. En Derecho, UCEDP, Certificado Formador Docente Profesional Presencial y Virtual, INFOTEP, Certificado Profesor de Educación Integral, ADESAEC. Reconocido por Organización Regional Americana de Jóvenes Emprendedores (Junior Achievement America's Región) por sus aportes de 10 años formando líderes emprendedores del mundo. Reconocido en 2008 por Federación Mundial de Jóvenes Líderes y Emprendedores por sus aportes como Ponente en la Convención Internacional de Niños de América, CINA. Reconocido en 2006 por la organización Mundial de Jóvenes Emprendedores (Junior Achievement Worldwide) por sus aportes formando 12 millones de jóvenes líderes emprendedores en el mundo. Reconocido en 2004 Centro Educativo Los Prados por formar en sus estudiantes la actitud emprendedora. Ha contribuido a la capacitación de colaboradores de as empresas: Cemento Panam, Acero Estrella, Ingeniería Estrella, Concredom, PIISA, Cuerpo de Paz, ASOBAL, Napco, RD, Tonos y Colores, Cervecería Nacional Dominicana, Sensata, CONVATEC, Eaton, Edwards Lifesciences, Fenwal International, Hospira, UASD, Unión Panamericana, Medtronic, Convergys, COPARDOM...

Aptitud y Actitud del Líder consciente de sí mismo.

YOEMPRESARIO, Mi Vida es Mi Empresa.

Play Episode Listen Later May 15, 2020 6:21

Todos somos líderes hechos a imagen y semejanza de nuestro creador. Como líderes debemos ser críticos de aquellos a quienes decidimos seguir o elegir como ejemplo. Depende de nuestra aptitud y actitud ante la vida ser pobre o rico. FRANCISCO YULI es Director General y Fundador de www.fundcioncedi.org, (CEDI), Conferencista, CEO de AYACAM. Productor y Conductor del Programa Emprendimiento Juvenil, Jueves 5-6pm., Radio Juventus Don Bosco. Productor y Conductor Segmento YO EMPRESARIO TV, Telecanal 28, Martes 6:30pm. a 7:00pm. Certificado y Reconocido por instituciones de Estados Unidos, México, Guatemala, Europa y República Dominicana formador de Líderes Emprendedores. Co-propulsor y Director de Programas de Formación de Lideres Juveniles Emprendedores JA por 13 años. Certificado de la Universidad de País Vasco, España en Derecho Internacional y Relaciones Internacionales. Magister en Derecho y Relaciones Internacionales, Universidad Autónoma de Santo Domingo. Certificado en Gerencia, Motivación y Supervisión de los Recursos Humanos, Universidad Pedro Henriquez Ureña (UNPHU), Lic. En Derecho, UCEDP, Certificado Formador Docente Profesional Presencial y Virtual, INFOTEP, Certificado Profesor de Educación Integral, ADESAEC. Reconocido por Organización Regional Americana de Jóvenes Emprendedores (Junior Achievement America's Región) por sus aportes de 10 años formando líderes emprendedores del mundo. Reconocido en 2008 por Federación Mundial de Jóvenes Líderes y Emprendedores por sus aportes como Ponente en la Convención Internacional de Niños de América, CINA. Reconocido en 2006 por la organización Mundial de Jóvenes Emprendedores (Junior Achievement Worldwide) por sus aportes formando 12 millones de jóvenes líderes emprendedores en el mundo. Reconocido en 2004 Centro Educativo Los Prados por formar en sus estudiantes la actitud emprendedora. Ha contribuido a la capacitación de colaboradores de as empresas: Cemento Panam, Acero Estrella, Ingeniería Estrella, Concredom, PIISA, Cuerpo de Paz, ASOBAL, Napco, RD, Tonos y Colores, Cervecería Nacional Dominicana, Sensata, CONVATEC, Eaton, Edwards Lifesciences, Fenwal International, Hospira, UASD, Unión Panamericana, Medtronic, Convergys, COPARDOM...

EL LIDER NACE O SE HACE EMPRESARIO?

YOEMPRESARIO, Mi Vida es Mi Empresa.

Play Episode Listen Later May 14, 2020 46:19

Aquí aprendes herramientas fundamentales de liderazgo para tu éxito personal. En esta entrevista de TV realizada por el Lic. Alfonso Ulloa al Lic. Francisco Yuli en el programa Voz para el Cambio. Sígueme en Instagram y YouTube como Yoempresario. Déjame tu opinión. www.fundacioncedi.org. FRANCISCO YULI, Director General y Fundador de www.fundcioncedi.org, (CEDI), Conferencista, CEO de AYACAM. Productor y Conductor del Programa Emprendimiento Juvenil, Jueves 5-6pm., Radio Juventus Don Bosco. Productor y Conductor Segmento YO EMPRESARIO TV, Telecanal 28, Martes 6:30pm. a 7:00pm. Certificado y Reconocido por instituciones de Estados Unidos, México, Guatemala, Europa y República Dominicana formador de Líderes Emprendedores. Co-propulsor y Director de Programas de Formación de Lideres Juveniles Emprendedores JA por 13 años. Certificado de la Universidad de País Vasco, España en Derecho Internacional y Relaciones Internacionales. Magister en Derecho y Relaciones Internacionales, Universidad Autónoma de Santo Domingo. Certificado en Gerencia, Motivación y Supervisión de los Recursos Humanos, Universidad Pedro Henriquez Ureña (UNPHU), Lic. En Derecho, UCEDP, Certificado Formador Docente Profesional Presencial y Virtual, INFOTEP, Certificado Profesor de Educación Integral, ADESAEC. Reconocido por Organización Regional Americana de Jóvenes Emprendedores (Junior Achievement America's Región) por sus aportes de 10 años formando líderes emprendedores del mundo. Reconocido en 2008 por Federación Mundial de Jóvenes Líderes y Emprendedores por sus aportes como Ponente en la Convención Internacional de Niños de América, CINA. Reconocido en 2006 por la organización Mundial de Jóvenes Emprendedores (Junior Achievement Worldwide) por sus aportes formando 12 millones de jóvenes líderes emprendedores en el mundo. Reconocido en 2004 Centro Educativo Los Prados por formar en sus estudiantes la actitud emprendedora. Ha contribuido a la capacitación de colaboradores de as empresas: Cemento Panam, Acero Estrella, Ingeniería Estrella, Concredom, PIISA, Cuerpo de Paz, ASOBAL, Napco, RD, Tonos y Colores, Cervecería Nacional Dominicana, Sensata, CONVATEC, Eaton, Edwards Lifesciences, Fenwal International, Hospira, UASD, Unión Panamericana, Medtronic, Convergys, COPARDOM...

Bonus 5: Convexity: Where Did it Come From and Where are We Now?

Play Episode Listen Later Dec 20, 2019 26:22

During this special bonus WOCTalk episode, I sit down with Jan Colwell to speak about the popular topic of convexity. Jan has practiced as a WOC nurse for 40 years at the University of Chicago Medicine and is currently the advanced practice nurse in the outpatient ostomy clinic. She is a Past President of the WOCN Society and Friends of Ostomates Worldwide USA, is the co-section editor of the ostomy section of the Journal of Wound, Ostomy and Continence Nursing and has edited several text books on ostomy care.In this episode, Jan speaks to us about the content from a recent WOCN Society webinar, Convexity: Where Did it Come From and Where Are We Now?, which provided a historical perspective on the use of convexity in the management of a patient with a stoma and examined different types of convexities. Listen in to learn about the past, present and future of convexity.This podcast and the webinar were supported by an educational grant from ConvaTec. The WOCN Society does not endorse specific products or services. For a list of WOC patient products and services, please click here.To view a free recording of the webinar Convexity: Where Did it Come From and Where Are We Now?, visit the webcasts section of the WOCN Society’s Continuing Education Center at wocn.org/cec.Click here to view the JWOCN article mentioned in this episode: Use of Convexity in Ostomy Care: Results of an International Consensus Meeting.

university friends journal wound past presidents woc chicago medicine ostomy where are we now convexity convatec international consensus meeting wocn society woctalk

Bonus 3: Convex Product Choices to Improve Care

merlin barclays capita british american tobacco entertainments inmarsat convatec

Play Episode Listen Later Aug 9, 2019 24:39

During this special bonus WOCTalk episode, we sit down with Donna Sellers, BSN, RN, CWON and Jill Hammond, BSN, RN, CWOCN of Convatec to speak about the content from the recent supported webinar, Convex Product Choices to Improve Patient Care. This session discussed the what and when of choosing convex product choices to improve patient care along with the potential risks and contraindications for using convexity. Listen in to learn more and on this topic and additional knowledge not covered during the original webinar recording. This podcast and the webinar were supported by Convatec. The WOCN Society does not endorse specific products or services. For a list of WOC patient products and services, please click here. To view a free recording of the webinar Convex Product Choices to Improve Patient Care, visit the webcasts section of the WOCN Society’s Continuing Education Center at wocn.org/cec. Additional Resources From this Episode: Use of Convexity in Pouching: A Comprehensive Review Hoeflok, Jo; Kittscha, Julia; Purnell, Paris Journal of Wound, Ostomy and Continence Nursing: September/October 2013 - Volume 40 - Issue 5 - p 506–512

care product choices rn wound bsn woc purnell convex ostomy convexity convatec wocn society woctalk

Quantium Cast Episode 1: Barclays, British American Tobacco, Convatec, Inmarsat, Merlin Entertainments and Capita

Quantium Research

Play Episode Listen Later Aug 3, 2019 15:54

Ryan Kia of Quantium Research summarises updates from: Barclays (BARC), British American Tobacco (BATS), Convatec (CTEC), Inmarsat (ISAT), Merlin Entertainments (MERL) and Capita (CPI).Disclaimer : Neither Ryan Kia nor anyone associated with "Quantium Research" holds any position whether long or short in any of the companies mentioned. As always, we aim to keep the most unbiased and informative tone as possible for the sake of our users on quantiumresearch.co.uk and our listeners on various streaming platforms.

Stakeholder management skills - Diane Mansfield

Venturi's Voice: Technology | Leadership | Staffing | Career | Innovation

Play Episode Listen Later Oct 5, 2018 27:21

Diane Mansfield is the Global Director of IM, BI and Data at ConvaTec Diane is a business and strategy consultant with 20+ years experience in Business Intelligence and Data. She has experience in shaping, defining and leading large strategic change management programs and associated transformation activities. Diane has skills in influencing, communication, facilitation and cross functional negotiation. ConvaTec ConvaTec holds a market leading positions in advanced wound care, ostomy care, continence and critical care and infusion devices. Their customers depend on their advanced technologies to help reduce potential complications of skin breakdown and infection, and they rely on ConvaTec’s products and services to help manage their conditions every day. Podcast Diane sat down with Andy to discuss stakeholder management, instigating cultural change in a business and hiring young technologists.

data bi mansfield global director business intelligence management skills stakeholder management convatec

#18 - Amy Oestreicher on Surviving Sexual Assault, PTSD, & Thriving

Mutually Amazing Podcast

Play Episode Listen Later Oct 3, 2018 32:49

Amy Oestreicher shares an open and honest conversation about PTSD and living life with PTSD. She discusses the role of creativity in a way that is not often discussed. You’ll hear of some wonderful resources in books and more in this thoughtful and helpful discussion with host Mike Domitrz. Links to Amy's book are: https://www.amazon.com/My-Beautiful-Detour-Unthinkable-Grateful/dp/1733138811/ref=redir_mobile_desktop?_encoding=UTF8&ref_=dbs_a_w_dp_1733138811 And all ebook and paperback versions are available at https://www.amyoes.com/mbd * You are invited to join our community and conversations about each episode on FaceBook at https://www.facebook.com/MutuallyAmazingPodcast and join us on Twitter @CenterRespect or visit our website at http://www.MutuallyAmazingPodcast.com** BIO of Amy Oestreicher: Amy Oestreicher is an Audie Award-nominated PTSD peer-to-peer specialist, artist, author, writer for The Huffington Post, speaker for TEDx and RAINN, health advocate, award-winning actress, and playwright. As a survivor and “thriver” of multiple traumas, Amy eagerly shares the gifts of life’s “beautiful detours” her educational programming, writing, mixed media art, performance and inspirational speaking. Amy has headlined international conferences on leadership, entrepreneurship, women’s rights, mental health, disability, creativity, and domestic violence prevention. She is a SheSource Expert, a “Top Mental Health” writer for Medium, and a regular lifestyle, wellness, and arts contributor for over 70 notable online and print publications, and and her story has appeared on NBC’s TODAY, CBS, Cosmopolitan, Seventeen Magazine, Washington Post, Good Housekeeping, MSNBC, among others. To celebrate her own “beautiful detour”, Amy created the #LoveMyDetour campaign, to help others cope in the face of unexpected events. Her passion for inclusion, equity and amplifying marginalized voices has earned her various honors, including a scholarship from the Association for Applied and Therapeutic Humor Professionals, the first annual SHERocks Herstory National Performing Artist Honoree, a United Way Community Helper award, and a National Sexual Education Grant honor. To creatively engage student advocacy efforts, Amy developed a trauma-informed program combining mental health education, sexual assault prevention, and Broadway Theatre for college campuses, organizations and conferences. She has designed a creative curriculum for “Detourist Resiliency,” an outreach program taken to schools, hospitals, and at-risk youth. She also has launched Detourist peer-led chapters on college campuses, Detourist creative arts workshops, and an online community to creatively fight stigma in society through storytelling. “Detourism” is also the subject of her TEDx Talk and upcoming book, My Beautiful Detour, available December 2017. As the 2014 Eastern Regional Recipient of Convatec’s Great Comebacks Award and WEGO Health 2016 “Health Activist Hero” Finalist, and WeGO Health Expert, Amy is a passionate voice in the ostomy community, founding the online community Fearless Ostomates, speaking for National and Regional WOCN conferences, and writing for the official print publication of the UOAA. Her presentations on alternative medicine, and patient advocacy and healthcare have also been accepted to international conferences on patient care, internal medicine, medical trauma and therapeutic humor in hospitals. She has devised workshops for the Transformative Language Arts Network National Conference, the Eating Recovery Foundation, the 40th Anniversary New England Educational Opportunity Association Milestones Conference, the Annual National Mental Health America Conference,2016 American College of Surgeons Clinical Congress, and others. She was the 2016 keynote speaker for the Hawaii Pacific Rim International Conference on Diversity and Disability. and will be the featured keynote speaker at the 2018 International School of Social Work Conference in Ohio. As a playwright, Amy has received awards and accolades for engaging her audiences in dynamic conversation on trauma’s effects on society, including Women Around Town’s “Women to Celebrate” 2014, BroadwayWorld “Best Theatre Debut,” Bistro Awards “New York Top Pick, and the “Singular Award” at the Sarasolo Theatre Festival, presented annually for a “performance that is exceptionally uncommon, groundbreaking, original and inventive.” Amy has written, directed and starred in a one-woman musical about her life, Gutless & Grateful, touring theatres, schools, festivals, conventions and organizations since it’s 2012 New York debut. Gutless & Grateful is currently being licensed to students across the country for academic projects and competitions. Amy spent Fall of 2015 participating as a playwright and performance artist in the National Musical Theatre Institute at the world-renowned Eugene O’Neill Theater Center, where she helped to develop the full-length multimedia ensemble piece, The Greeks Are Trying to Tell Us Something, and was a writer, actress, composer and set designer for “Playwrights and Librettists” – a festival of 27 30-minute plays in five days. Her original, full-length drama, Imprints, exploring the physical and psychological impact of trauma, premiered at the Producer’s Club in 2016, and is currently in development for a full New York production as Flicker and a Firestarter. Her short plays have been published by the Eddy Theatre Company and finalists in Manhattan Repertory Theatre’s Short Play Festival, as well as NYC Playwright’s Women in the Age of Drumpf. Her theatre education essays and monologues have been published in Creative Pedagogy journals, as part of a theatre curriculum for high school students in the Philippines, and as a teaching artist, she is a strong advocate for arts integration and education. Amy’s collaboration with Beechwood Arts on the immersion salon, “Resilience and the Power of the Human Spirit”, has traveled around the world to health and arts facilities as a public installation, incorporating her monologues, art, writing and recipes to express the life-altering detours and ultimately the invaluable gifts of her resilient journey. Amy is also an active artist and teacher in the Jewish community, being honored by United Way in 2005 for her music programs at Hollander House, completing artist residencies at Art Kibbutz, and delivering “Hope, Resilience & Biblical Women” keynotes for synagogues and religious schools. After studying Theatre of the Oppressed in her studies at Hampshire College, she helped to train ACTSmart, a Playback Theatre troupe in Amherst, MA. She is also a passionate arts education advocate, a successful mixed media visual artist, a continuing education studio arts teacher, and an active member of the League of Professional Theatre Women, League for Advancement of New England Storytellers, Fairfield County Cultural Alliance, Alliance for Jewish Theatre, Theatre Artist Workshop, and several art guilds throughout Connecticut and New York. Amy is currently developing a multimedia performance project incorporate her original music compositions with the oral histories of her grandmother, a holocaust survivor with musical director David Brunetti, and developing a new multidisciplinary solo musical based on herthird TEDx Talk this year: healing from trauma through the archetypal hero’s journey. She is also working on a full-length play with music, LEFTOVERS with director and dramaturge Susan Einhorn, based on her life after the surgical ICU. She is leading mixed media creativity and solo performance workshops to promote creativity as a mindset, an essential survival skill. Amy also offers creative coaching and consulting services help others navigate their own “life detours,” and prides herself most on ending each night with a gratitude list. As the creator of Gutless & Grateful, her one-women autobiographical musical, Amy has toured theatres nationwide. She also premiered her drama, Imprints, at NYC Producers Club in May 2016, about how trauma affects the family as well as the victim. Her #LoveMyDetour campaign helps others cope with unexpected events. “Detourism” is also the subject of her upcoming TEDx talk and book My Beautiful Detour. LINKS: www.amyoes.com Amy's Social Media: Facebook page: https://www.facebook.com/amyoestr and facebook.com/lovemydetour Linkedin: linkedin.com/in/amyoes Or you can subscribe to G+: https://plus.google.com/u/0/106058010956085677457/posts Pinterest: https://www.pinterest.com/amyoes70/allspice-acrylics-a-celebration-of-life-and-beauti/ Youtube: https://www.youtube.com/user/AmyOes70 Tumblr: https://www.tumblr.com/blog/amyoes stumbleupon: http://www.stumbleupon.com/stumbler/amyoes700 Bloglovin: https://www.bloglovin.com/blogs/amyoes-14356407 Twitter: @amyoes Instagram: @amyoes70 Link to R.A.I.N.N. (Rape, Abuse, & Incest National Network) at www.rainn.org Books Amy Recommends: Amy’s Book: My Beautiful Detour New World Theatre’s “Solitary Voice: A Collection of Epic Monologues” Nevertheless She Persusted by Tanya Eby & 8 Others The Hero’s Journey by Joseph Campbell Waking the Tiger by Peter Levine and Ann Frederick The Courage to Heal by Laura Davis and Ellen Bass The Body Keeps the Score by Bessel Van der Kolk MD and Sean Pratt READ THE FULL TRANSCRIPTION of the EPISODE HERE (or download the pdf): **IMPORTANT: This podcast episode was transcribed by a 3rd party service and so errors can occur throughout the following pages: Mike: Welcome to the respect podcast. I'm your host, Mike Domitrz from mikespeaks.com, where we help organizations of all sizes, educational institutions, and the U.S. military create a culture of respect, and respect is exactly what we discuss on this show. So let's get started. This week's episode, we want to get right into it here 'cause you're going to be incredibly inspired by our guest's journey back to wholeness and reclaiming her voice using creativity as her lifeline. She gratefully discovered the upside of obstacles. Today Amy is a PTSD specialist, artist, author, Tedx, and Rain speaker, award-winning actress, a playwright, and mental health advocate. That is Amy Oestreicher. Thank you, Amy, so much for joining us. Amy: Thank you for having me. I'm excited to be here. Mike: Absolutely. And so we want to dive right into this. The show, obviously, is all about respect, but you bring a different perspective in that you talk about PTSD and trauma. And let's get right into that. So when people hear trauma and PTSD, what form, or does it matter, that you're referring to? Amy: Well, what I'm referring to is, there's trauma that comes from many setbacks and many unexpected twists and turns in my life that I didn't expect, that really didn't come to my realization until years and years later. So for PTSD, something can impact us that can completely change our lives overnight, and we might sit with that for a bit, and slowly we feel that something isn't right. I don't feel the same. And slowly those memories come to surface, and I found my way through piecing together those memories and finding healing through creativity. PTSD, for me, started, with being sexually abused by a teacher that I trusted. And an example of a symptom of PTSD is the freeze response, where you don't think anything has happened, and you kind of wake up and go about your life, and think everything's as you were, and suddenly something is off, disassociation, meaning the world is around you, and you're somewhere apart from it wondering what's going on. Amy: I did not say no or fight back, although my mind was clearly thinking those things, but I just froze. I saw myself as somewhere separate. And years later it would take a lot of work to kind of bring those memories to light and start to heal through remembering all of that. Mike: Well, one, I want to thank you for sharing your journey, your strength, your courage as a survivor. And I think this is an important topic because a lot of times when people hear freeze, they think that the natural human response is freeze or flight or fight. They tend to think, oh, most people flight or fight. They think that, and they forget that freeze is actually the most natural human reaction under stress in our DNA system as human beings, because back in the times of cave people, you did not fight the creature there was 20 times larger than you. Amy: Right, right. Mike: You either played dead, freeze, or you ran. Fight was the last thing you did. So a lot of times people hear it and they go, "Why didn't you fight?" Because it's the last innate response that the human body is likely to have because naturally it's to freeze or to run. And in certain situations, running's not an option. Child teacher, you can definitely feel like, I don't have that option. So to freeze is the natural thing to occur, and I think too often people don't realize that. Amy: Exactly. Mike: And so I think for anybody listening, thinking that, saying, "Well, why didn't the person fighter? Or what ..." Those are not innately in our DNA. So the body reacts under stress to its most innate natural things that it thinks it should do, that saved it over thousands of years of human being in existence. And that's what can happen in that moment. Is that true? Amy: It's true, and I love to bring up an amazing resource that I found that, that changed my perspective on the freeze response. It's called ... It's a book called Waking the Tiger by Peter Levine. And what caught me, and what you brought up is, Peter Levine spent a lot of time just studying animals in the wild, and he saw that a gazelle when it's kind of running free it ... And a predator attacks it, it just plays dead. And then once the attack is over, it will just get up and just run and run and run and discharge that natural energy and restore its homeostasis and be back to normal. And Peter Levine was like, "Well, why can't humans do that? Why did we get stuck in that?" And, well, we have a brain, and we think ourselves, we overthink ourselves, and we stay frozen in that nestle, that bunches of energy, when really we just need to discharge that energy like the gazelle that is running through the wild. And we need to find a healthy container to get that capsulated energy out and bring it to light. Amy: Eventually through talking about it and sharing it or whatever feels like a release to you, but he really, Peter Levine really took his cues from these animals in the wild that have this freeze response in them, and they know how to know from it. And I think the community really needs to understand what goes on in the freeze response to really support survivors and understand that this may be all tucked in and it needs to be brought to light. Mike: Yeah. And one of the problems that communities can put on survivors at times is trying to understand why the survivor did what they did, instead of not understanding, the issue is what the predator did, not with the survivor did or did not do. To focus on whether the survivor fought back or run is missing the point. It's all about what the predator did. Now we need to be supportive of the survivor so that they can, like you said, be able to live that life, to be able to live a full life. Amy: Right. Or, "Why didn't you tell someone right away?" Your words often come last. Again, It's that you think of a kaleidoscope of ... I am an artist, so I've been creatively ... colors coming together, red anxiety or anger or fear, and the person just does not have those words. I mean, it takes time. But the, I think the important first step is the community needs to be so informed of what the freeze response is and be there for their survivors and believe them. Mike: Yes, well that's essential. And it is interesting because, depending on where PTSD has been discussed, people treat it differently. Military PTSD tends to be treated differently than sexual violence PTSD that's a result of sexual violence, because the military, and I get to work with the military all over the world, we thankfully are grateful from our military. Not everybody is, but a lot of people are. So when they look at the military, they go, "There's a hero who is struggling with something that happened because they sacrificed for our country." And so therefore there's empathy, there's understanding for that person. Yet there's not always the same toward sexual violence survivors. They don't have that same. Why do you think that is? Amy: Well, you have to remember, too, that it took a long time for those stories to be told as well. My grandmother was a Holocaust survivor, and I think about how she coped just coming right out of the war before PTSD was even a word. I think for survivors of sexual violence the encouraging part is it now is becoming talked about much more than when it happened to me. And I say keep going with that. But there are more blurry lines with that, especially with what's shown to us on the media, with messages we've gotten from the past from culture and things like that. And now we're all trying to kind of make a new game plan. But it is kind of a fuzzy area because things that have seemed okay to other people in the past, well, now these survivors' stories are being told, and we see that, you know when this happened, this was not okay. Amy: So I think it's our job, to be honest, everyone's job to make those boundaries just as clear that, just as PTSD is an atrocity with certain communities, it is an atrocity with survivors of sexual violence. I'm also a survivor of PTSD from almost 30 surgeries from another unexpected medical-related crisis. And I dealt with the same thing, that once I was done with all my surgeries and stitched up and ready to go, doctors thought, well, the physical part of me was healed, so why couldn't I just move on to the rest of my life? Whenever we encounter any kind of change in our life, where our life seems to just twist overnight, we need that support from those around us to know that it's going to take time for us to process that change, and we need to talk about it. Mike: Yeah. And that's so important. And that goes into you ... In your work you talk about sharing your story and why somebody sharing their story's so important. Can you share for our listeners, our viewers, why that is such an important journey? Amy: Yes. I didn't realize how important it was. My situation was very atypical, I guess. I guess unexpected, like anyone else would, but I was 18, and just a blood clot on caused me to go into many, many surgeries that changed my life overnight. And because of medical circumstances, I was very isolated for almost a decade. And so I didn't really have many people to talk to. I had my doctors, and I had my loving parents, and that's all. But slowly I started to write a little bit, and again, another book that inspired me was Joseph Campbell learning about, uh, the archetypal hero's journey, and I actually found my way through this dark, unanticipated chapter in my life through tracing Joseph Campbell's steps to what makes a hero in society and how they have to go away for a while and then come back transformed. I mean, it's in every Pixar movie, the heroes or in your Star Wars. And so I kind of used that as my own map. And so slowly I was typing. PART 1 OF 3 ENDS [00:12:04] Amy: Use that as my own map, and so, slowly, I was typing and typing to kind of uncover what I had been through for myself. That was only a very initial step because this was still all me realizing these things for myself. Then, years later, I finally was able to share it through theater, which I had always loved doing as a kid and which I thought was going to be my life. I ended up making that story arc into a one-woman musical that I've been touring since 2012, but it's very funny. That was the first time I'd ever shared anything about what I had been through, and in the very first opening venue in New York, I said one line about the sexual abuse. And it was very difficult for me. I didn't know whether it fit in with everything else, and then, over the years, as I became more and more comfortable with that, talking about it, more people that came to see my show came up to me and said, you know, "Something similar had happened to me." And I'd started the conversation. Amy: And now, I've expanded on the show, where I do go into that a lot and the healing that came come from it and the community that can come, so, I guess, writing my show and performing it was an example, for me, of how just planting the seed of just starting your story and getting to share it and share it and talk to other people, it can make you move on or go to the next step that you need to go to. Mike: And you're a big advocate of using creativity in that process, as you've explained. Amy: Yeah. Mike: So, yeah, you created the show, a one-woman, one-person show, that really has a powerful impact. If somebody's listening, going, "I'm just not creative. I am not an artist. I am not a performer- Amy: No, no, no- Mike: -I get- Amy: -don't say that. Mike: I know. I know, but that's what people are going to thing, so- Amy: I know. Mike: -we need to address that. I think there's a misunderstanding what creativity means, so can you explain what we mean by "creativity" and why- Amy: Totally. Mike: -it's so important and can be such a great resource in the process? Amy: Yes. Creativity is really just a mindset. I couldn't talk for many months after my surgeries because I had all these things going on, tubes in and out of me, and then I couldn't talk at times where I felt too shocked at everything going around me to even say a word. And I missed singing, and I wanted to go back to that. But that's when I started ... I picked up a paint brush by accident in one of the hospitals, started just painting, but by creativity is really just a way to see things differently. So, it means just taking a walk outside, taking a breath, looking at the tree and finding grounding by a tree in a new way. It means cooking a recipe you've always loved. It means putting a little bit of that locked-up energy that you'll ... that passion that was always there before all this that can never be taken away by any kind of trauma. It just gets frozen like a gazelle. You're playing dead. Amy: Creativity is a way to unlock that clenched-up energy and just bring it forward, and don't worry about the final steps of "Well, how am I gonna tell about what happened to me?" Just focus on that, those uncomfortable feelings you might feel in the freeze response, which is the anxiety, the pain, the fear. Feel that energy and see if there's a color. Start with that and see it in the sky or something and really just ... I got to say one more time, before you start working about how we're gonna show it to the community, just focus on getting out that energy for yourself and seeing that you were in there all along. You just got bring it to life somehow. Mike: Yeah. And you can choose to never share it with the community. It could be your process for your own journey. Amy: Exactly. Mike: And that's what I love about how you're describing creativity. I have always remembered. I was speaking to a doctor, and I work with a doctor who's both general practitioner and also holistic, so both sides of the equation. Mike: And he was once saying to me, "Hey, Mike, on a scale of one to three in how you feel the world [inaudible 00:16:49] the world, you're a three, very high, like, off-the-charts three. You feel everything in the world, which means you're a high creative," and I jumped back and went "Whoa, whoa, whoa, whoa. I don't do art. I don't write music. I love to sing, but I'm horrible at it. Like, I do not have artistic traits." And he went, "What? You get on stage and you share with people your thoughts and ideas. That's a very creative process in how that works and how you put the thoughts together and how you connect, and you're a massive problem-solver. That's what you love to do." So, that's all creativity, so I think- Amy: Oh, yeah. Mike: -for people listening, pause and go, "Are you a problem-solver? Because if you are, that's a high-level form of creativity. You're trying to creatively come up with a solution when you're problem-solving." Amy: Exactly. Yeah. It just means taking an unexpected turn and saying, "All right. I'll go with it and see what happens." And we never know what's coming next, so if you have creativity, that is your best resource because then you can just say, "Okay, unexpected twist, I'm gonna just follow you and use my magic reassembling creativity problem-solving skills to figure out whatever comes next." Mike: Yeah. And it's very natural, as a Buddhist approach, that we let go of the outcome, right, that we be present in the journey, let go of the outcome because when you're outcome-focused, it actually kills your creativity because- Amy: And [inaudible 00:18:11] the outcome. Mike: -you're creating pressure. Right. You're saying there has to be this end result versus actually just being free to the possibilities. That's creativity. Amy: Exactly. Mike: It is freedom of possibility, so I love that conversation. Amy: Open mind. Mike: Yes. Yeah, exactly. How do you think we help society as a whole have a universal empathy when we can't relate to what somebody else has been through? Somebody hears that and goes, "Well, why didn't they do this?" Or "Why didn't they do that?" And what's happening is they're watching through their lenses. They're thinking through their lenses and thinking, "I would've done this. At least, I think I would've. So, how in the world did they do that?" How do we help people understand that empathy means, "I don't think about it how I would've done it. I think about what they must have been going through, and I will never- Amy: Right. Mike: -fully understand it 'cause I wasn't there, but at least I'm trying to be compassionate from that viewpoint?" Amy: Right. I mean, I come from an acting background, and the first thing I remember learning is awareness without judgment. We're aware of everyone else around us, of everything else around us, but we don't judge. But, with these circumstances, I think, honestly, having been through it and now supporting other survivors of violence, I really think we all need to up our game and, again, be educated on PTSD and the various responses that can only not ... not only affect the survivors themselves, but the people that care about them. It can affect other communities and things they're going through. I mean, trauma both a universal and historical and ... we'll keep going because life changes. So, I think we're all better off if we understand what can happen, and we're ... as humans, we're all always going to think, "Well, I would've done this," or "I would've said 'No,'" or "I would've ...." Amy: I think, again, we can have those thoughts, but at the end of the day, we really have to understand that this is trauma. And I want to be open to whatever this person is sharing with me or chooses to share. Mike: Yeah. Amy: It's having respect. Mike: That's just it. It's treating everybody with respect and dignity, and in the wake of sexual violence, sometimes there's destructive coping strategies that show themselves- Amy: Exactly. Mike: -for a survivor and that can amplify symptoms of PTSD. And you used the word "victimization." Couple things. Those listening, when we say "destructive," what do we mean by that 'cause they might understand what that means and how do you help somebody who's experiencing that? Amy: So, destructive coping mechanisms. I'm gonna go back to that energy that survivors feel that has not been discharged. When we carry a secret, [inaudible 00:21:14] are like poison. They burdensome. They weigh down, and so those can often be coped with in anything from drugs and alcohol to other symptoms to any other way that we can find to become numb, whether it's scrolling up and down on Facebook all day. It's any way that we are trying to ignore that energy and kind of just close off and not deal with those things, and it takes a lot of bravery and a lot of courage to really look at that energy for what it is and maybe even remember a bit of what happened and how you felt. But it's a very important part of the process because all those destructive coping mechanisms ... really, it's about energy. Think of that energy that the gazelle wishes they could be running off and around with. It's that energy we need to get out, that we feel like we have to close down. Mike: Well, and I want to step in there because I, in this line of work ... and I'm sure you run into the same thing. People come up to me and go, "I have someone close to me in my life who either I know or I highly suspect is a survivor of sexual violence, but they have not told anyone. And I can see the destructive coping strategies in their life. How do I help them?" And what happens when they ask that question is there's two approaches. There's the "How do I help them? How do I support them?" And there's the "How do I fix them?" Which are two very different approaches. Amy: Yeah. [inaudible 00:23:02] true. Mike: Help and support is what people need. Being fixed is never gonna work with a human being. You don't fix people. I've made that mistake of trying to be a fixer in my life over [inaudible 00:23:12]. There were times, where I looked back, when I was trying to fix the person versus be supportive of the person, so how do we, instead of trying to fix them, how do we provide support when it's ... they're not asking for it? They have not come forward. I mean, verbally, asking for it. They're not outwardly saying, "Will you support me? Will you help me?" They haven't even told anyone that they are struggling with this. How do you help and support that person? Amy: And, honestly, they're role is very, very different because I think it's human instinct to want to fix people. When we see people struggling, we want to reach out, and we want to help them so badly. Surprisingly, the best way to help and support is not such a hands-on, fixing approach as you might have wanted. It's to really just ... being there as- PART 2 OF 3 ENDS [00:24:04] Amy: It's really just being there as a listener, as a gentle, compassionate listener. And if you need to say, "I believe you" ... It's taking in the words they're saying or whatever they're giving you. Mike: Yeah, because they might not tell you. They might not be in a believe you moment, because they might not tell you. And that's why saying that I'm here for you. If anything ever has happened or ever does, that's the language we teach our audiences. If anybody ever has or does. That way you're opening the door to possibilities of what could've already happened or what could happen in the future. It's so important for the person to understand, I'm here for you. And then the tough part is, you have to be patient. Amy: Right. Mike: Because they may not want to tell you for ten years, and that's their journey. It's not your right to invade and change their journey on them. Or ever. Or maybe they want to tell you right then, but it's their journey which means you have to be patient and understand this isn't about me finding out, or me being told. It's about them and being present for them. Amy: Yeah. And for those of you that are listening going, "That's it?" I get it, it's so simple and it's so difficult to just leave it at that, just be there. But it's that support. I always go back to theater and military veterans that the Greek plays of Sophocles about war and all those things. Those were originally meant for veterans of the war to come in and share their story to the community to get that community compassion, to have people know what they were going through. And there are other rituals that we still do today like dancing and group singing and all those things that show that our need for community is so important. So, survivors of sexual violence, if you feel kind of that no one in the community understands you, please know that coming back to the community is just such an important part of healing, even if it's scary. And for those that see these people struggling, just welcome them in and don't ask questions, don't demand answers. Just, we need to stay welcome with open arms. Mike: I love that you pointed out "Don't ask questions." Because that sounds like you're prying and you're investigating, which can very quickly turn into ... whether intentional or not, unintended victim-blaming is what can happen there. Amy: Right. Mike: So just listening is so important. Now, a great resource out there that you speak for, you're a RAINN speaker, is RAINN. Which for anybody listening is Rape Abuse and Incest National Network, RAINN.org. They also have an eight hundred number on their website, and you can call them and it's actually 656-HOPE, I think, is the eight hundred number. But you can call, you can email, and they'll hook you up with resources locally that are confidential and twenty-four seven. They can tell you what those are, but they can also just start by being there for you. It's a great organization. What are some additional resources that you feel are vital for survivors to know if somebody's listening right now and is experiencing PTSD? Amy: Right. So, first of all, I can't say enough good things about RAINN. They will connect you to anything ... and anonymously. I know a lot of people who are worried about saying who they are or saying who they feel the perpetrator was. You don't have to worry about that. They will take you wherever you are right now. Some books that really helped me again were Waking the Tiger by Peter Levine. He started this whole kind of therapy with the body called somatic experiencing, which is all about using breath work to really feel your body again. And another book that helped me understand is called The Body Keeps the Score by Dr. Bessel Van Der Kolk. But in terms of online resources, PTSD.org, there are so many resources there. Mike: So you just said that's PTSD.org? Amy: Yes. Mike: Okay, I just want to make sure we have all that on our show notes, for anybody who's listening so they can find that there. Amy: Right. And again, any of these places will connect you to someone ... Oh, no, that's not even there anymore. Oh my God. I will have to send you a new link for that. I'm sorry about that. Mike: Which link are you referring to? Amy: I was actually referring to PTS- Mike: Oh, yes, you're right, I see that now. There's nothing there. So that's okay, we'll have the link to RAINN- Amy: I will get you- Mike: -and we'll have links to all the books you've brought up, we'll have that in the show notes. Let's get into some more books here that you recommend for people. One is your own, your book, My Beautiful Detour. Another one is New World Theater Solitary Voice: A collection of epic monologues. And then you have Nevertheless We Persisted by Tanya Eby and others. If you want to dive in, why those three books? Obviously we'll start with yours, My Beautiful Detour. Amy: That's on pre-order now, I'm very excited for that because it is the whole story of a long-winded detour and lots of PTSD, where I felt very isolated and felt like no one understands me, I can't reach out for help, who would get this? But then how all this creativity ... and I say "creativity" in this general term of a mindset, kind of figuring this out as I went along ... how that really helped me along my journey. And eventually how I was able to reach out. I talk about being a detourist, where you see a detour in the path and you find a little creativity and find your way through. So besides talking about my story and how I healed, I also have a lot of really good plans for when life crashes over night and you need to find a way out again. So, I hope it's helpful. Mike: Absolutely. Well, I appreciate that. It's in a pre-order so it's still on its way, but people can get it now, so as soon as it comes out. And then, New World Theater Solitary Voice: A collection of epic monologues. What about that one? Amy: Well, again, I listed these because, again, the monologue that I wrote for this is actually how I originally discovered I was sexually abused, by picking up a book on a bookshelf, which is really the important resource that I wanted to bring up called The Courage to Heal, Laura Davis, and I'll have to ... The Courage to Heal really saved my life. It's a workbook for survivors of sexual violence and since then there have been editions for their caretakers to fill out with the survivors. There have been many recent versions, but I can't say enough about the book, The Courage to Heal. So, this book that just came out has a monologue where I talk about that first time that I take that up. Amy: And then this last, Nevertheless We Persisted, is actually a collection. It was nominated for an Audie Award this spring of monologues and stories about finding a voice in total darkness. So I hope those performances are very inspiring, as well. Mike: No, I appreciate that. And your book and your stories, you're getting the messages out there. Now, the one book that you just mentioned, The Courage to Heal, if somebody's looking for that, there's two different versions by completely different authors. There's How to Overcome Sexual Abuse and Childhood Trauma. There's also A Guide for Women Survivors of Child Sexual Abuse. Which one were you referencing? Amy: Right. So I was referencing the one that originally changed my life by Laura Davis and Ellen Bass. Mike: Got it, the Guide for Women Survivors of Child Sexual Abuse, okay. Amy: Right. Mike: Just so our listeners are hearing, I want to make sure we give them the right one. And we'll have that in the show notes, we're going to have all these in the show notes. Amy: Yes. Mike: So I want to thank you so much, Amy. Amy: Thank you. Mike: For everyone listening, this is Amy Oestriecher. Amy: Hi. Mike: Our show notes will have all of the links to Amy, 'cause she gave us a lot for social media. All these books, I'm going to have it all there so you can find it all there. Remember you can also jump in this discussion on Facebook, we have a discussion group called The RESPECT Podcast discussion group, jump in there on the conversation, subscribe on iTunes. We love it if you leave a review, too, that always helps. So, Amy, thank you so much for joining us. Amy: Thank you. Thank you. Mike: Thank you for joining us for this episode of The RESPECT Podcast, which was sponsored by The DATE SAFE Project at datesafeproject.org. And remember, you can always find me at mikespeaks.com. PART 3 OF 3 ENDS [00:33:25]

god women new york power guide fall star wars child club ohio diversity dna courage creativity national open jewish theater resilience greek celebrate ptsd league surviving nbc heal rain fight thriving cbs medium washington post couple connecticut sexual tedx abuse tiger philippines pinterest ends alliance pixar score huffington post holocaust disability buddhist bio rape msnbc assault icu sexual assault advancement waking american colleges cosmopolitan leftovers tedx talks applied childhood trauma united way joseph campbell amherst oppressed firestarter good housekeeping body keeps rainn international school child sexual abuse human spirit flicker peter levine sophocles playwrights bessel van der kolk hampshire college imprints seventeen magazine laura davis incest national network audie award drumpf bessel van oestreicher tell us something broadway theatre ellen bass mike domitrz wego health amy oestreicher sean pratt date safe project playback theatre convatec bloglovin rape abuse kolk md lovemydetour manhattan repertory theatre my beautiful detour gutless grateful detourism

Marc Reuss, EVP & CHRO, ConvaTec Group

HR Leaders

Play Episode Listen Later Aug 14, 2017 21:52

Episode #5 - We are joined by Marc Reuss, EVP & CHRO, ConvaTec Group. Watch the video footage from the podcast here: http://bit.ly/HRDLeadersPodcast.

From Coma to Career ~ Cultivating Creativity

Inspirational Business Women Show

Play Episode Listen Later Jun 14, 2017 50:34

Have you ever taken a detour in your career and wondered why things weren’t going as you planned? You’re going to love this week’s guest, Amy Oestreicher, CEO of Gutless & Grateful. Amy survived an unexpected bloodclot & stomach rupture that left her in a coma for months, followed by 27 surgeries, organ failure, on-going trauma and PTSD over the next 10 years. That’s quite a detour! You will be incredibly inspired by her journey back to wholeness and a satisfying career, using creativity as her lifeline. She gratefully discovered the “upside of obstacles.” Today, Amy is a PTSD specialist, artist, author, TEDx & RAINN speaker, award-wining actress, playwrite and mental health advocate. Amy is the recipient of Convatec’s “Great Comebacks Award”. Her story has appeared on NBC’s TODAY, CBS, Cosmopolitan and over 70 online and print publications including the Huffington Post. This week’s hot topics will cover: • Transforming Adversity into Creative Growth • The Four Hardcore Skills to Resilience • How to Love your Detours & Achieve Lofty Goals As the creator of Gutless & Grateful, her one-women autobiographical musical, Amy has toured theatres nationwide. She also premiered her drama, Imprints, at NYC Producers Club in May 2016, about how trauma affects the family as well as the victim. Her #LoveMyDetour campaign helps others cope with unexpected events. “Detourism” is also the subject of her upcoming TEDx talk and book My Beautiful Detour.

love ceo career resilience ptsd nbc cbs tedx huffington post cosmopolitan coma imprints cultivating creativity amy oestreicher convatec my beautiful detour gutless grateful detourism

Episode 15: Interview with Amy Oestreicher

LaughBox

Play Episode Listen Later May 16, 2017 34:45

Look out…up ahead…A DETOUR! This week, on Laughbox, I have the great pleasure of talking with Amy Oestreicher. She’s funny, she’s talented, and she knows about the detours in life. She shares her story and how she’s learned to shift mindset and be more resilient. I think you’ll enjoy the interview…she’s VERY high energy! A little more on Amy… Amy Oestreicher is a PTSD peer-to-peer specialist, artist, author, writer for The Huffington Post, speaker for TEDx and RAINN, health advocate, award-winning actress, and playwright. As a survivor and “thriver” of multiple traumas, Amy eagerly shares the gifts of life’s “beautiful detours” her educational programming, writing, mixed media art, performance and inspirational speaking. Amy has headlined international conferences on leadership, entrepreneurship, women’s rights, mental health, disability, creativity, and domestic violence prevention. She is a SheSource Expert, a “Top Mental Health” writer for Medium, and a regular lifestyle, wellness, and arts contributor for over 70 notable online and print publications, and her story has appeared on NBC’s TODAY, CBS, Cosmopolitan, Seventeen Magazine, Washington Post, Good Housekeeping, MSNBC, among others. To celebrate her own “beautiful detour”, Amy created the #LoveMyDetour campaign, to help others cope in the face of unexpected events. Her passion for inclusion, equity and amplifying marginalized voices has earned her various honors, including a scholarship from the Association for Applied and Therapeutic Humor Professionals, the first annual SHERocks Herstory National Performing Artist Honoree, a United Way Community Helper award, and a National Sexual Education Grant honor. To creatively engage student advocacy efforts, Amy developed a trauma-informed program combining mental health education, sexual assault prevention, and Broadway Theatre for college campuses, organizations and conferences. She has designed a creative curriculum for “Detourist Resiliency,” an outreach program taken to schools, hospitals, and at-risk youth. She also has launched Detourist peer-led chapters on college campuses, Detourist creative arts workshops, and an online community to creatively fight stigma in society through storytelling. “Detourism” is also the subject of her TEDx Talk and upcoming book, My Beautiful Detour, available December 2017. As the 2014 Eastern Regional Recipient of Convatec’s Great Comebacks Award and WEGO Health 2016 “Health Activist Hero” Finalist, and WeGO Health Expert, Amy is a passionate voice in the ostomy community, founding the online community Fearless Ostomates, speaking for National and Regional WOCN conferences, and writing for the official print publication of the UOAA. Her presentations on alternative medicine and patient advocacy and healthcare have also been accepted to international conferences on patient care, internal medicine, medical trauma and therapeutic humor in hospitals. She has devised workshops for the Transformative Language Arts Network National Conference, the Eating Recovery Foundation, the 40th Anniversary New England Educational Opportunity Association Milestones Conference, the Annual National Mental Health America Conference,2016 American College of Surgeons Clinical Congress, and others. She was the 2016 keynote speaker for the Hawaii Pacific Rim International Conference on Diversity and Disability. and will be the featured keynote speaker at the 2018 International School of Social Work Conference in Ohio. As a playwright, Amy has received awards and accolades for engaging her audiences in dynamic conversation on trauma’s effects on society, including Women Around Town’s “Women to Celebrate” 2014, BroadwayWorld “Best Theatre Debut,” Bistro Awards “New York Top Pick, and the “Singular Award” at the Sarasolo Theatre Festival, presented annually for a “performance that is exceptionally uncommon, groundbreaking, original and inventive.” Amy has written, directed and starred in a one-woman musical about her life, Gutless & Grateful, touring theatres, schools, festivals, conventions and organizations since it’s 2012 New York debut. Gutless & Grateful is currently being licensed to students across the country for academic projects and competitions. Amy spent Fall of 2015 participating as a playwright and performance artist in the National Musical Theatre Institute at the world-renowned Eugene O’Neill Theater Center, where she helped to develop the full-length multimedia ensemble piece, The Greeks Are Trying to Tell Us Something, and was a writer, actress, composer and set designer for “Playwrights and Librettists” – a festival of 27 30-minute plays in five days. Her original, full-length drama, Imprints, exploring the physical and psychological impact of trauma, premiered at the Producer’s Club in 2016, and is currently in development for a full New York production as Flicker and a Firestarter. Her short plays have been published by the Eddy Theatre Company and finalists in Manhattan Repertory Theatre’s Short Play Festival, as well as NYC Playwright’s Women in the Age of Trump. Her theatre education essays and monologues have been published in Creative Pedagogy journals, as part of a theatre curriculum for high school students in the Philippines, and as a teaching artist, she is a strong advocate for arts integration and education. Amy’s collaboration with Beechwood Arts on the immersion salon, “Resilience and the Power of the Human Spirit”, has traveled around the world to health and arts facilities as a public installation, incorporating her monologues, art, writing and recipes to express the life-altering detours and ultimately the invaluable gifts of her resilient journey. Amy is also an active artist and teacher in the Jewish community, being honored by United Way in 2005 for her music programs at Hollander House, completing artist residencies at Art Kibbutz, and delivering “Hope, Resilience & Biblical Women” keynotes for synagogues and religious schools. After studying Theatre of the Oppressed in her studies at Hampshire College, she helped to train ACTSmart, a Playback Theatre troupe in Amherst, MA. She is also a passionate arts education advocate, a successful mixed media visual artist, a continuing education studio arts teacher, and an active member of the League of Professional Theatre Women, League for Advancement of New England Storytellers, Fairfield County Cultural Alliance, Alliance for Jewish Theatre, Theatre Artist Workshop, and several art guilds throughout Connecticut and New York. Amy is currently developing a multimedia performance project incorporate her original music compositions with the oral histories of her grandmother, a holocaust survivor with musical director David Brunetti, and developing a new multidisciplinary solo musical based on er second TEDx Talk this year: healing from trauma through the archetypal hero’s journey. She is also working on a full-length play with music, LEFTOVERS with director and dramaturge Susan Einhorn, based on her life after the surgical ICU. She is leading mixed media creativity and solo performance workshops to promote creativity as a mindset, an essential survival skill. Amy also offers creative coaching and consulting services help others navigate their own “life detours,” and prides herself most on ending each night with a gratitude list.

women new york donald trump power fall club ohio diversity national jewish theater resilience celebrate league cbs medium washington post connecticut alliance huffington post disability msnbc icu advancement cosmopolitan leftovers tedx talks applied united way detour amherst oppressed firestarter good housekeeping human spirit flicker playwrights hampshire college seventeen magazine tell us something broadway theatre wego health amy oestreicher playback theatre convatec lovemydetour manhattan repertory theatre gutless grateful detourism

AirPlay Presents: Amy Oestreicher's Musical Gutless & Grateful

Play Episode Listen Later Dec 26, 2016 15:10

Coni Koepfinger hosts today's Air Play. With Interview of Amy Oesreicher. Plus Highlights from Amy's Live Performance.Amy Oestreicher is a PTSD peer-to-peer specialist, artist, author, writer for Huffington Post, speaker for TEDx and RAINN, health advocate, survivor, award-winning actress, and playwright, sharing the lessons learned from trauma through her writing, mixed media art, performance and inspirational speaking. As the creator of "Gutless & Grateful," her BroadwayWorld-nominated one-woman autobiographical musical, she's toured theatres nationwide, along with a program combining mental health advocacy, sexual assault awareness and Broadway Theatre for college campuses and international conferences. Her original, full-length drama, Imprints, premiered at the NYC Producer's Club in May 2016, exploring how trauma affects the family as well as the individual. To celebrate her own “beautiful detour”, Amy created the #LoveMyDetour campaign, to help others cope in the face of unexpected events. "Detourism" is also the subject of her TEDx and upcoming book, My Beautiful Detour, available December 2017. As Eastern Regional Recipient of Convatec’s Great Comebacks Award, she's spoken to hundreds of healthcare professionals at national WOCN conferences, and her presentations on diversity, leadership and trauma have been featured at National Mental Health America Conference, New England Educational Opportunity Association's 40 Anniversary Conference, and have been keynotes at the Pacific Rim Conference of Diversity and Disability in Hawaii, the Eating Recovery Foundation First Annual Benefit in Colorado. She's contributed to over 70 notable online and print publications, and her story has appeared on NBC's TODAY, CBS, Cosmopolitan, among others. Learn more: amyoes.com and support her work at patreon.com/amyo. Amy is currently participating as a playwright and performance artist in the National Musical Theatre Institute at the world-renowned Eugene O'Neill Theater Center.-- Amy OestreicherActress, Artist, Playwright, Author, Speaker, Survivor, and DetouristHuffington Post Columnist, TEDx, Great Comebacks Recipient SheSource Expert Featured in Cosmopolitan, & NBC's TODAY*Celebrating Life's Beautiful Detours Through Creative PTSD Education & Mental Health Programming*Award-Winning Musical Gutless & Grateful: See '17 NYC DatesSocial Media Channels)

club colorado artist speaker diversity hawaii theater ptsd nbc musical survivors cbs tedx grateful huffington post disability cosmopolitan playwright live performances rainn airplay imprints broadwayworld gutless broadway theatre anniversary conference amy oestreicher convatec lovemydetour my beautiful detour gutless grateful detourism coni koepfinger

AirPlay Presents: Amy Oestreicher's Musical Gutless & Grateful

Play Episode Listen Later Dec 26, 2016 15:10

colorado artist speaker diversity hawaii theater ptsd musical survivors cbs tedx grateful huffington post disability cosmopolitan playwright rainn airplay imprints broadwayworld gutless broadway theatre anniversary conference amy oestreicher convatec nbc's today lovemydetour my beautiful detour gutless grateful detourism coni koepfinger eugene o'neill theater center

AirPlay Presents an Interview of Amy Oestreicher

Play Episode Listen Later Nov 28, 2016 18:24

Coni Koepfinger hosts today's Air Play. With Interview of Amy Oesreicher. Plus a reading of Amy's Play by Christy Donahue.Amy Oestreicher is a PTSD peer-to-peer specialist, artist, author, writer for Huffington Post, speaker for TEDx and RAINN, health advocate, survivor, award-winning actress, and playwright, sharing the lessons learned from trauma through her writing, mixed media art, performance and inspirational speaking. As the creator of "Gutless & Grateful," her BroadwayWorld-nominated one-woman autobiographical musical, she's toured theatres nationwide, along with a program combining mental health advocacy, sexual assault awareness and Broadway Theatre for college campuses and international conferences. Her original, full-length drama, Imprints, premiered at the NYC Producer's Club in May 2016, exploring how trauma affects the family as well as the individual. To celebrate her own “beautiful detour”, Amy created the #LoveMyDetour campaign, to help others cope in the face of unexpected events. "Detourism" is also the subject of her TEDx and upcoming book, My Beautiful Detour, available December 2017. As Eastern Regional Recipient of Convatec’s Great Comebacks Award, she's spoken to hundreds of healthcare professionals at national WOCN conferences, and her presentations on diversity, leadership and trauma have been featured at National Mental Health America Conference, New England Educational Opportunity Association's 40 Anniversary Conference, and have been keynotes at the Pacific Rim Conference of Diversity and Disability in Hawaii, the Eating Recovery Foundation First Annual Benefit in Colorado. She's contributed to over 70 notable online and print publications, and her story has appeared on NBC's TODAY, CBS, Cosmopolitan, among others. Learn more: amyoes.com and support her work at patreon.com/amyo. Amy is currently participating as a playwright and performance artist in the National Musical Theatre Institute at the world-renowned Eugene O'Neill Theater Center.-- Amy OestreicherActress, Artist, Playwright, Author, Speaker, Survivor, and DetouristHuffington Post Columnist, TEDx, Great Comebacks Recipient SheSource Expert Featured in Cosmopolitan, & NBC's TODAY*Celebrating Life's Beautiful Detours Through Creative PTSD Education & Mental Health Programming*Award-Winning Musical Gutless & Grateful: See '17 NYC DatesSocial Media Channels)

club colorado artist speaker diversity hawaii ptsd nbc survivors cbs tedx huffington post disability cosmopolitan playwright rainn airplay imprints broadwayworld broadway theatre anniversary conference amy oestreicher convatec lovemydetour my beautiful detour gutless grateful detourism coni koepfinger christy donahue

AirPlay Presents an Interview of Amy Oestreicher